# Official Journal C 22/2010

| | ISSN 1725-2423
  doi:10.3000/17252423.C_2010.022.eng |
| --- | --- |
| Official Journal
  of the European Union | C 22 |
| | |
| English edition | Information and Notices | Volume 5329 January 2010 |

ISSN 1725-2423

doi:10.3000/17252423.C_2010.022.eng

Official Journal

of the European Union

C 22

English edition

Information and Notices

Volume 5329 January 2010

---

| Notice No | Contents | page |
| --- | --- | --- |
| | IV   Notices |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2010/C 022/01 | Euro exchange rates | 1 |
| 2010/C 022/02 | Summary of Community decisions on marketing authorisations in respect of medicinal products from 1 November 2009 to 30 November 2009(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
  ) | 2 |
| 2010/C 022/03 | Summary of Community decisions on marketing authorisations in respect of medicinal products from 1 November 2009 to 30 November 2009(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council
  or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council
  ) | 13 |
| 2010/C 022/04 | Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 December 2009 to 31 December 2009(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
  ) | 18 |
| 2010/C 022/05 | Summary of Community decisions on marketing authorisations in respect of medicinal products from 1 December 2009 to 31 December 2009(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council
  or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council
  ) | 28 |
| | Court of Auditors |
| 2010/C 022/06 | Special Report No 17/2009 concerning vocational training actions for women co-financed by the European Social Fund | 29 |
| | NOTICES FROM MEMBER STATES |
| 2010/C 022/07 | Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 800/2008 declaring certain categories of aid compatible with the common market in application of Articles 87 and 88 of the Treaty (General Block Exemption Regulation) (
  1
  ) | 30 |
| 2010/C 022/08 | Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 800/2008 declaring certain categories of aid compatible with the common market in application of Articles 87 and 88 of the Treaty (General Block Exemption Regulation) (
  1
  ) | 36 |
| 2010/C 022/09 | Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 800/2008 declaring certain categories of aid compatible with the common market in application of Articles 87 and 88 of the Treaty (General Block Exemption Regulation) (
  1
  ) | 41 |

Notice No

Contents

page

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2010/C 022/01

Euro exchange rates

1

2010/C 022/02

Summary of Community decisions on marketing authorisations in respect of medicinal products from 1 November 2009 to 30 November 2009(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
  )

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council

)

2

2010/C 022/03

Summary of Community decisions on marketing authorisations in respect of medicinal products from 1 November 2009 to 30 November 2009(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council
  or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council
  )

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council

or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council

)

13

2010/C 022/04

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 December 2009 to 31 December 2009(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
  )

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council

)

18

2010/C 022/05

Summary of Community decisions on marketing authorisations in respect of medicinal products from 1 December 2009 to 31 December 2009(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council
  or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council
  )

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council

or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council

)

28

Court of Auditors

2010/C 022/06

Special Report No 17/2009 concerning vocational training actions for women co-financed by the European Social Fund

29

NOTICES FROM MEMBER STATES

2010/C 022/07

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 800/2008 declaring certain categories of aid compatible with the common market in application of Articles 87 and 88 of the Treaty (General Block Exemption Regulation) (
  1
  )

1

30

2010/C 022/08

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 800/2008 declaring certain categories of aid compatible with the common market in application of Articles 87 and 88 of the Treaty (General Block Exemption Regulation) (
  1
  )

1

36

2010/C 022/09

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 800/2008 declaring certain categories of aid compatible with the common market in application of Articles 87 and 88 of the Treaty (General Block Exemption Regulation) (
  1
  )

1

41

| | V   Announcements |
| --- | --- |
| | PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
| | European Commission |
| 2010/C 022/10 | Communication from the Minister for Economic Affairs of the Kingdom of the Netherlands pursuant to Article 3(2) of Directive 94/22/EC of the European Parliament and of the Council on the conditions for granting and using authorisations for the prospection, exploration and production of hydrocarbons | 46 |
| | OTHER ACTS |
| | European Commission |
| 2010/C 022/11 | Publication of an amendment application pursuant to Article 6(2) of Council Regulation (EC) No 510/2006 on the protection of geographical indications and designations of origin for agricultural products and foodstuffs | 48 |
| 2010/C 022/12 | Publication of an application pursuant to Article 6(2) of Council Regulation (EC) No 510/2006 on the protection of geographical indications and designations of origin for agricultural products and foodstuffs | 52 |

V   Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

2010/C 022/10

Communication from the Minister for Economic Affairs of the Kingdom of the Netherlands pursuant to Article 3(2) of Directive 94/22/EC of the European Parliament and of the Council on the conditions for granting and using authorisations for the prospection, exploration and production of hydrocarbons

46

OTHER ACTS

European Commission

2010/C 022/11

Publication of an amendment application pursuant to Article 6(2) of Council Regulation (EC) No 510/2006 on the protection of geographical indications and designations of origin for agricultural products and foodstuffs

48

2010/C 022/12

Publication of an application pursuant to Article 6(2) of Council Regulation (EC) No 510/2006 on the protection of geographical indications and designations of origin for agricultural products and foodstuffs

52

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | |
| --- | --- |

EN

---

IV Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

| 29.1.2010 | EN | Official Journal of the European Union | C 22/1 |
| --- | --- | --- | --- |

29.1.2010

EN

Official Journal of the European Union

C 22/1

---

Euro exchange rates (1)

28 January 2010

2010/C 22/01

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,3999 |
| JPY | Japanese yen | 126,36 |
| DKK | Danish krone | 7,4447 |
| GBP | Pound sterling | 0,86160 |
| SEK | Swedish krona | 10,2021 |
| CHF | Swiss franc | 1,4725 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 8,1790 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 26,232 |
| EEK | Estonian kroon | 15,6466 |
| HUF | Hungarian forint | 271,30 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,7083 |
| PLN | Polish zloty | 4,0705 |
| RON | Romanian leu | 4,1360 |
| TRY | Turkish lira | 2,0898 |
| AUD | Australian dollar | 1,5537 |
| CAD | Canadian dollar | 1,4824 |
| HKD | Hong Kong dollar | 10,8755 |
| NZD | New Zealand dollar | 1,9695 |
| SGD | Singapore dollar | 1,9623 |
| KRW | South Korean won | 1 612,18 |
| ZAR | South African rand | 10,6097 |
| CNY | Chinese yuan renminbi | 9,5570 |
| HRK | Croatian kuna | 7,3210 |
| IDR | Indonesian rupiah | 13 050,19 |
| MYR | Malaysian ringgit | 4,7719 |
| PHP | Philippine peso | 65,232 |
| RUB | Russian rouble | 42,4650 |
| THB | Thai baht | 46,316 |
| BRL | Brazilian real | 2,5882 |
| MXN | Mexican peso | 18,1179 |
| INR | Indian rupee | 64,7870 |

Currency

Exchange rate

USD

US dollar

1,3999

JPY

Japanese yen

126,36

DKK

Danish krone

7,4447

GBP

Pound sterling

0,86160

SEK

Swedish krona

10,2021

CHF

Swiss franc

1,4725

ISK

Iceland króna

NOK

Norwegian krone

8,1790

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

26,232

EEK

Estonian kroon

15,6466

HUF

Hungarian forint

271,30

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,7083

PLN

Polish zloty

4,0705

RON

Romanian leu

4,1360

TRY

Turkish lira

2,0898

AUD

Australian dollar

1,5537

CAD

Canadian dollar

1,4824

HKD

Hong Kong dollar

10,8755

NZD

New Zealand dollar

1,9695

SGD

Singapore dollar

1,9623

KRW

South Korean won

1 612,18

ZAR

South African rand

10,6097

CNY

Chinese yuan renminbi

9,5570

HRK

Croatian kuna

7,3210

IDR

Indonesian rupiah

13 050,19

MYR

Malaysian ringgit

4,7719

PHP

Philippine peso

65,232

RUB

Russian rouble

42,4650

THB

Thai baht

46,316

BRL

Brazilian real

2,5882

MXN

Mexican peso

18,1179

INR

Indian rupee

64,7870

---

(1)  Source: reference exchange rate published by the ECB.

---

| 29.1.2010 | EN | Official Journal of the European Union | C 22/2 |
| --- | --- | --- | --- |

29.1.2010

EN

Official Journal of the European Union

C 22/2

---

Summary of Community decisions on marketing authorisations in respect of medicinal products from 1 November 2009 to 30 November 2009

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
   (1)
  )

2010/C 22/02

—   Issuing of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | INN (International Non-Proprietary Name) | Holder of the marketing authorisation | Number of the entry in the Community Register | Pharmaceutical form | ATC code (Anatomical Therapeutic Chemical Code) | Date of notification |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 4.11.2009 | Repaglinide Krka | Repaglinide | KRKA, d. d. |
| Novo mesto |
| Šmarješka cesta 6 |
| SI-8501 Novo mesto |
| SLOVENIJA |

Date of the decision

Name of the medicinal product

INN (International Non-Proprietary Name)

Holder of the marketing authorisation

Number of the entry in the Community Register

Pharmaceutical form

ATC code (Anatomical Therapeutic Chemical Code)

Date of notification

4.11.2009

Repaglinide Krka

Repaglinide

KRKA, d. d.

Novo mesto

Šmarješka cesta 6

SI-8501 Novo mesto

SLOVENIJA

EU/1/09/579/001-018

Tablet

A10B X02

6.11.2009

4.11.2009

Copalia HCT

amlodipine besylate/valsartan/hydrochlorothiazide

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex |
| RH12 5AB |
| UNITED KINGDOM |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex

RH12 5AB

UNITED KINGDOM

EU/1/09/575/001-060

Film-coated tablet

C09DX01

6.11.2009

4.11.2009

Dafiro HCT

amlodipine besylate/valsartan/hydrochlorothiazide

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex |
| RH12 5AB |
| UNITED KINGDOM |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex

RH12 5AB

UNITED KINGDOM

EU/1/09/574/001-060

Film-coated tablet

C09DX01

6.11.2009

26.11.2009

Multaq

dronedarone

| Sanofi-Aventis |
| --- |
| 174 avenue de France |
| 75013 Paris |
| FRANCE |

Sanofi-Aventis

174 avenue de France

75013 Paris

FRANCE

EU/1/09/591/001-004

Film-coated tablet

Not applicable

1.12.2009

26.11.2009

Irbesartan/Hydrochlorothiazide Teva

hydrochlorothiazide

| Teva Pharma B.V. |
| --- |
| Computerweg 10 |
| 3542 DR Utrecht |
| NEDERLAND |

Teva Pharma B.V.

Computerweg 10

3542 DR Utrecht

NEDERLAND

EU/1/09/583/001-072

Film-coated tablet

C09D A04

1.12.2009

30.11.2009

Sildenafil Teva

Sildenafil

| Teva Pharma B.V. |
| --- |
| Computerweg 10 |
| 3542 DR Utrecht |
| NEDERLAND |

Teva Pharma B.V.

Computerweg 10

3542 DR Utrecht

NEDERLAND

EU/1/09/584/001-018

Film-coated tablet

G04BE03

2.12.2009

30.11.2009

Nevirapine Teva

nevirapine

| Teva Pharma B.V. |
| --- |
| Computerweg 10 |
| 3542 DR Utrecht |
| NEDERLAND |

Teva Pharma B.V.

Computerweg 10

3542 DR Utrecht

NEDERLAND

EU/1/09/598/001-004

Tablet

J05AG01

2.12.2009

30.11.2009

Hirobriz Breezhaler

Indacaterol

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex |
| RH12 5AB |
| UNITED KINGDOM |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex

RH12 5AB

UNITED KINGDOM

EU/1/09/594/001-010

Inhalation powder

Not applicable

2.12.2009

30.11.2009

Onbrez Breezhaler

Indacaterol

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex |
| RH12 5AB |
| UNITED KINGDOM |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex

RH12 5AB

UNITED KINGDOM

EU/1/09/593/001-010

Inhalation powder

Not applicable

2.12.2009

30.11.2009

Oslif Breezhaler

Indacaterol

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex |
| RH12 5AB |
| UNITED KINGDOM |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex

RH12 5AB

UNITED KINGDOM

EU/1/09/586/001-010

Inhalation powder

Not applicable

2.12.2009

30.11.2009

Zutectra

Human Hepatitis B Immunoglobulin

| Biotest Pharma GmbH |
| --- |
| Landsteinerstr. 5 |
| 63303 Dreieich |
| DEUTSCHLAND |

Biotest Pharma GmbH

Landsteinerstr. 5

63303 Dreieich

DEUTSCHLAND

EU/1/09/600/001

Solution for injection

J06BB04

2.12.2009

—   Modification of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorisation | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 4.11.2009 | Intelence | Janssen-Cilag International NV |
| Turnhoutseweg 30 |
| 2340 Beerse |
| BELGIË |

Date of the decision

Name of the medicinal product

Holder of the marketing authorisation

Number of the entry in the Community Register

Date of notification

4.11.2009

Intelence

Janssen-Cilag International NV

Turnhoutseweg 30

2340 Beerse

BELGIË

EU/1/08/468/001

6.11.2009

4.11.2009

Optisulin

| Sanofi-Aventis Deutschland GmbH |
| --- |
| 65926 Frankfurt am Main |
| DEUTSCHLAND |

Sanofi-Aventis Deutschland GmbH

65926 Frankfurt am Main

DEUTSCHLAND

EU/1/00/133/001-032

6.11.2009

4.11.2009

Lantus

| Sanofi-Aventis Deutschland GmbH |
| --- |
| 65926 Frankfurt am Main |
| DEUTSCHLAND |

Sanofi-Aventis Deutschland GmbH

65926 Frankfurt am Main

DEUTSCHLAND

EU/1/00/134/001-037

6.11.2009

4.11.2009

Ketek

| Aventis Pharma S.A. |
| --- |
| 20 avenue Raymond Aron |
| 92160 Antony |
| FRANCE |

Aventis Pharma S.A.

20 avenue Raymond Aron

92160 Antony

FRANCE

EU/1/01/191/001-005

6.11.2009

4.11.2009

Osseor

| Les Laboratoires Servier |
| --- |
| 22 rue Garnier |
| 92200 Neuilly-sur-Seine |
| FRANCE |

Les Laboratoires Servier

22 rue Garnier

92200 Neuilly-sur-Seine

FRANCE

EU/1/04/287/001-006

6.11.2009

4.11.2009

Protelos

| Les Laboratoires Servier |
| --- |
| 22 rue Garnier |
| 92200 Neuilly-sur-Seine |
| FRANCE |

Les Laboratoires Servier

22 rue Garnier

92200 Neuilly-sur-Seine

FRANCE

EU/1/04/288/001-006

6.11.2009

5.11.2009

Abilify

| Otsuka Pharmaceutical Europe Ltd |
| --- |
| Hunton House |
| Highbridge Business Park |
| Oxford Road |
| Uxbridge |
| Middlesex |
| UB8 1HU |
| UNITED KINGDOM |

Otsuka Pharmaceutical Europe Ltd

Hunton House

Highbridge Business Park

Oxford Road

Uxbridge

Middlesex

UB8 1HU

UNITED KINGDOM

EU/1/04/276/001-020

EU/1/04/276/024-036

10.11.2009

5.11.2009

Tyverb

| Glaxo Group Limited |
| --- |
| Berkeley Avenue |
| Greenford |
| Middlesex |
| UB6 0NN |
| UNITED KINGDOM |

Glaxo Group Limited

Berkeley Avenue

Greenford

Middlesex

UB6 0NN

UNITED KINGDOM

EU/1/07/440/001-002

9.11.2009

5.11.2009

Pre-pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals

| GlaxoSmithKline Biologicals S.A. |
| --- |
| Rue de l'Institut 89 |
| 1330 Rixensart |
| BELGIQUE |

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut 89

1330 Rixensart

BELGIQUE

EU/1/08/478/001

9.11.2009

5.11.2009

Celsentri

| Pfizer Limited |
| --- |
| Ramsgate Road |
| Sandwich |
| Kent |
| CT13 9NJ |
| UNITED KINGDOM |

Pfizer Limited

Ramsgate Road

Sandwich

Kent

CT13 9NJ

UNITED KINGDOM

EU/1/07/418/001-010

9.11.2009

5.11.2009

Invega

| Janssen-Cilag International NV |
| --- |
| Turnhoutseweg 30 |
| 2340 Beerse |
| BELGIË |

Janssen-Cilag International NV

Turnhoutseweg 30

2340 Beerse

BELGIË

EU/1/07/395/001-095

9.11.2009

5.11.2009

Foscan

| Biolitec Pharma Ltd |
| --- |
| United Drug House |
| Magna Drive |
| Dublin 24 |
| IRELAND |

Biolitec Pharma Ltd

United Drug House

Magna Drive

Dublin 24

IRELAND

EU/1/01/197/003-005

9.11.2009

6.11.2009

Fosavance

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire |
| EN11 9BU |
| UNITED KINGDOM |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire

EN11 9BU

UNITED KINGDOM

EU/1/05/310/001-009

10.11.2009

9.11.2009

Januvia

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire |
| EN11 9BU |
| UNITED KINGDOM |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire

EN11 9BU

UNITED KINGDOM

EU/1/07/383/001-018

11.11.2009

11.11.2009

Celvapan

| Baxter AG |
| --- |
| Industriestraße 67 |
| 1221 Wien |
| ÖSTERREICH |

Baxter AG

Industriestraße 67

1221 Wien

ÖSTERREICH

EU/1/08/506/001

12.11.2009

11.11.2009

Focetria

| Novartis Vaccines and Diagnostics S.r.l. |
| --- |
| Via Fiorentina 1 |
| 53100 Siena SI |
| ITALIA |

Novartis Vaccines and Diagnostics S.r.l.

Via Fiorentina 1

53100 Siena SI

ITALIA

EU/1/07/385/001-002

EU/1/07/385/004

12.11.2009

11.11.2009

Pandemrix

| GlaxoSmithKline Biologicals S.A. |
| --- |
| Rue de l'Institut 89 |
| 1330 Rixensart |
| BELGIQUE |

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut 89

1330 Rixensart

BELGIQUE

EU/1/08/452/001

12.11.2009

11.11.2009

Insuman

| Sanofi-Aventis Deutschland GmbH |
| --- |
| 65926 Frankfurt am Main |
| DEUTSCHLAND |

Sanofi-Aventis Deutschland GmbH

65926 Frankfurt am Main

DEUTSCHLAND

EU/1/97/030/028-195

13.11.2009

11.11.2009

PegIntron

Schering Plough Europe

| Rue de Stalle 73 |
| --- |
| 1180 Bruxelles |
| BELGIQUE |

Rue de Stalle 73

1180 Bruxelles

BELGIQUE

| Stallestraat 73 |
| --- |
| 1180 Brussel |
| BELGIË |

Stallestraat 73

1180 Brussel

BELGIË

EU/1/00/131/001-050

13.11.2009

11.11.2009

Soliris

| Alexion Europe S.A.S. |
| --- |
| 25 boulevard de l'Amiral Bruix |
| 75016 Paris |
| FRANCE |

Alexion Europe S.A.S.

25 boulevard de l'Amiral Bruix

75016 Paris

FRANCE

EU/1/07/393/001

13.11.2009

11.11.2009

Rebetol

Schering Plough Europe

| Rue de Stalle 73 |
| --- |
| 1180 Bruxelles |
| BELGIQUE |

Rue de Stalle 73

1180 Bruxelles

BELGIQUE

| Stallestraat 73 |
| --- |
| 1180 Brussel |
| BELGIË |

Stallestraat 73

1180 Brussel

BELGIË

EU/1/99/107/001-005

13.11.2009

12.11.2009

Intelence

| Janssen-Cilag International NV |
| --- |
| Turnhoutseweg 30 |
| 2340 Beerse |
| BELGIË |

Janssen-Cilag International NV

Turnhoutseweg 30

2340 Beerse

BELGIË

EU/1/08/468/001

17.11.2009

12.11.2009

IntronA

Schering Plough Europe

| Rue de Stalle 73 |
| --- |
| 1180 Bruxelles |
| BELGIQUE |

Rue de Stalle 73

1180 Bruxelles

BELGIQUE

| Stallestraat 73 |
| --- |
| 1180 Brussel |
| BELGIË |

Stallestraat 73

1180 Brussel

BELGIË

EU/1/99/127/001-044

17.11.2009

12.11.2009

ViraferonPeg

Schering Plough Europe

| Rue de Stalle 73 |
| --- |
| 1180 Bruxelles |
| BELGIQUE |

Rue de Stalle 73

1180 Bruxelles

BELGIQUE

| Stallestraat 73 |
| --- |
| 1180 Brussel |
| BELGIË |

Stallestraat 73

1180 Brussel

BELGIË

EU/1/00/132/001-050

17.11.2009

19.11.2009

IntronA

Schering Plough Europe

| Rue de Stalle 73 |
| --- |
| 1180 Bruxelles |
| BELGIQUE |

Rue de Stalle 73

1180 Bruxelles

BELGIQUE

| Stallestraat 73 |
| --- |
| 1180 Brussel |
| BELGIË |

Stallestraat 73

1180 Brussel

BELGIË

EU/1/99/127/031-039

23.11.2009

19.11.2009

Clopidogrel Teva Pharma

Teva Pharma B.V.

| Computerweg 10 |
| --- |
| 3542 DR Utrecht |
| NEDERLAND |

Computerweg 10

3542 DR Utrecht

NEDERLAND

| HCS bvba, H. |
| --- |
| Kennisstraat 53 |
| 2650 Edegem |
| BELGIË |

HCS bvba, H.

Kennisstraat 53

2650 Edegem

BELGIË

EU/1/09/561/001-009

23.11.2009

20.11.2009

Circadin

| RAD Neurim Pharmaceuticals EEC Limited |
| --- |
| One Forbury Square |
| The Forbury, Reading |
| Berkshire |
| RG1 3EB |
| UNITED KINGDOM |

RAD Neurim Pharmaceuticals EEC Limited

One Forbury Square

The Forbury, Reading

Berkshire

RG1 3EB

UNITED KINGDOM

EU/1/07/392/001-002

18.12.2009

20.11.2009

Bondronat

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City |
| AL7 1TW |
| UNITED KINGDOM |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City

AL7 1TW

UNITED KINGDOM

EU/1/96/012/004

EU/1/96/012/009-013

24.11.2009

20.11.2009

Ebixa

| H. Lundbeck A/S |
| --- |
| Ottiliavej 9 |
| 2500 Valby |
| DANMARK |

H. Lundbeck A/S

Ottiliavej 9

2500 Valby

DANMARK

EU/1/02/219/001-003

EU/1/02/219/005-049

24.11.2009

20.11.2009

Mycamine

| Astellas Pharma Europe B.V. |
| --- |
| Elisabethhof 19 |
| 2353 EW Leiderdorp |
| NEDERLAND |

Astellas Pharma Europe B.V.

Elisabethhof 19

2353 EW Leiderdorp

NEDERLAND

EU/1/08/448/001-002

24.11.2009

20.11.2009

NeoRecormon

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City |
| AL7 1TW |
| UNITED KINGDOM |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City

AL7 1TW

UNITED KINGDOM

EU/1/97/031/019-046

24.11.2009

20.11.2009

MabCampath

| Genzyme Europe B.V. |
| --- |
| Gooimeer 10 |
| 1411 DD Naarden |
| NEDERLAND |

Genzyme Europe B.V.

Gooimeer 10

1411 DD Naarden

NEDERLAND

EU/1/01/193/001-002

24.11.2009

20.11.2009

Somavert

| Pfizer Ltd |
| --- |
| Ramsgate Road |
| Sandwich |
| Kent |
| CT13 9NJ |
| UNITED KINGDOM |

Pfizer Ltd

Ramsgate Road

Sandwich

Kent

CT13 9NJ

UNITED KINGDOM

EU/1/02/240/001-004

24.11.2009

20.11.2009

Reyataz

| Bristol-Myers Squibb Pharma EEIG |
| --- |
| Uxbridge Business Park |
| Sanderson Road |
| Uxbridge |
| UB8 1DH |
| UNITED KINGDOM |

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park

Sanderson Road

Uxbridge

UB8 1DH

UNITED KINGDOM

EU/1/03/267/001-010

24.11.2009

20.11.2009

Xeristar

| Boehringer Ingelheim International GmbH |
| --- |
| Binger Straße 173 |
| 55216 Ingelheim am Rhein |
| DEUTSCHLAND |

Boehringer Ingelheim International GmbH

Binger Straße 173

55216 Ingelheim am Rhein

DEUTSCHLAND

EU/1/04/297/001-008

24.11.2009

20.11.2009

Regranex

| Janssen-Cilag International NV |
| --- |
| Turnhoutseweg 30 |
| 2340 Beerse |
| BELGIË |

Janssen-Cilag International NV

Turnhoutseweg 30

2340 Beerse

BELGIË

EU/1/99/101/001

24.11.2009

20.11.2009

Ziagen

| Glaxo Group Ltd |
| --- |
| Greenford |
| Middlesex |
| UB6 0NN |
| UNITED KINGDOM |

Glaxo Group Ltd

Greenford

Middlesex

UB6 0NN

UNITED KINGDOM

EU/1/99/112/001-002

24.11.2009

20.11.2009

Cymbalta

| Eli Lilly Nederland B.V. |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| NEDERLAND |

Eli Lilly Nederland B.V.

Grootslag 1-5

3991 RA Houten

NEDERLAND

EU/1/04/296/001-009

24.11.2009

20.11.2009

Angiox

| The Medicines Company UK Ltd |
| --- |
| 115 L Milton Park |
| Abingdon |
| Oxfordshire |
| OX14 4SA |
| UNITED KINGDOM |

The Medicines Company UK Ltd

115 L Milton Park

Abingdon

Oxfordshire

OX14 4SA

UNITED KINGDOM

EU/1/04/289/001-002

24.11.2009

20.11.2009

Agenerase

| Glaxo Group Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex |
| UB6 0NN |
| UNITED KINGDOM |

Glaxo Group Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex

UB6 0NN

UNITED KINGDOM

EU/1/00/148/001-004

24.11.2009

20.11.2009

RoActemra

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City |
| AL7 1TW |
| UNITED KINGDOM |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City

AL7 1TW

UNITED KINGDOM

EU/1/08/492/001-006

24.11.2009

23.11.2009

Nexavar

| Bayer Schering Pharma AG |
| --- |
| 13342 Berlin |
| DEUTSCHLAND |

Bayer Schering Pharma AG

13342 Berlin

DEUTSCHLAND

EU/1/06/342/001

25.11.2009

23.11.2009

Noxafil

SP Europe

| Rue de Stalle 73 |
| --- |
| 1180 Bruxelles |
| BELGIQUE |

Rue de Stalle 73

1180 Bruxelles

BELGIQUE

| Stallestraat 73 |
| --- |
| 1180 Brussel |
| BELGIË |

Stallestraat 73

1180 Brussel

BELGIË

EU/1/05/320/001

25.11.2009

23.11.2009

Pritor

| Bayer Schering Pharma AG |
| --- |
| 13342 Berlin |
| DEUTSCHLAND |

Bayer Schering Pharma AG

13342 Berlin

DEUTSCHLAND

EU/1/98/089/001-022

25.11.2009

23.11.2009

Aptivus

| Boehringer Ingelheim International GmbH |
| --- |
| Binger Straße 173 |
| 55216 Ingelheim am Rhein |
| DEUTSCHLAND |

Boehringer Ingelheim International GmbH

Binger Straße 173

55216 Ingelheim am Rhein

DEUTSCHLAND

EU/1/05/315/001-002

26.11.2009

23.11.2009

Exjade

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex |
| RH12 5AB |
| UNITED KINGDOM |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex

RH12 5AB

UNITED KINGDOM

EU/1/06/356/001-009

25.11.2009

23.11.2009

Cervarix

| GlaxoSmithKline Biologicals S.A. |
| --- |
| Rue de l'Institut 89 |
| 1330 Rixensart |
| BELGIQUE |

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut 89

1330 Rixensart

BELGIQUE

EU/1/07/419/001-012

25.11.2009

23.11.2009

Trizivir

| Glaxo Group Ltd |
| --- |
| Greenford Road |
| Greenford |
| Middlesex |
| UB6 0NN |
| UNITED KINGDOM |

Glaxo Group Ltd

Greenford Road

Greenford

Middlesex

UB6 0NN

UNITED KINGDOM

EU/1/00/156/002-003

25.11.2009

23.11.2009

Telzir

| Glaxo Group Ltd |
| --- |
| Greenford Road |
| Greenford |
| Middlesex |
| UB6 0NN |
| UNITED KINGDOM |

Glaxo Group Ltd

Greenford Road

Greenford

Middlesex

UB6 0NN

UNITED KINGDOM

EU/1/04/282/001-002

25.11.2009

23.11.2009

Azilect

| Teva Pharma GmbH |
| --- |
| Kandelstrasse 10 |
| 79199 Kirchzarten |
| DEUTSCHLAND |

Teva Pharma GmbH

Kandelstrasse 10

79199 Kirchzarten

DEUTSCHLAND

EU/1/04/304/001-007

25.11.2009

23.11.2009

Invega

| Janssen-Cilag International NV |
| --- |
| Turnhoutseweg 30 |
| 2340 Beerse |
| BELGIË |

Janssen-Cilag International NV

Turnhoutseweg 30

2340 Beerse

BELGIË

EU/1/07/395/001-095

25.11.2009

23.11.2009

Puregon

| Organon N.V. |
| --- |
| Kloosterstraat 6 |
| Postbus 20 |
| 5340 BH Oss |
| NEDERLAND |

Organon N.V.

Kloosterstraat 6

Postbus 20

5340 BH Oss

NEDERLAND

EU/1/96/008/001-041

25.11.2009

23.11.2009

Kinzalmono

| Bayer Schering Pharma AG |
| --- |
| 13342 Berlin |
| DEUTSCHLAND |

Bayer Schering Pharma AG

13342 Berlin

DEUTSCHLAND

EU/1/98/091/001-014

25.11.2009

23.11.2009

Micardis

| Boehringer Ingelheim International GmbH |
| --- |
| Binger Straße 173 |
| 55216 Ingelheim am Rhein |
| DEUTSCHLAND |

Boehringer Ingelheim International GmbH

Binger Straße 173

55216 Ingelheim am Rhein

DEUTSCHLAND

EU/1/98/090/001-020

26.11.2009

23.11.2009

Kaletra

| Abbott Laboratories Ltd |
| --- |
| Queenborough |
| Kent |
| ME11 5EL |
| UNITED KINGDOM |

Abbott Laboratories Ltd

Queenborough

Kent

ME11 5EL

UNITED KINGDOM

EU/1/01/172/001-007

25.11.2009

24.11.2009

Synagis

| Abbott Laboratories Ltd |
| --- |
| Queenborough |
| Kent |
| ME11 5EL |
| UNITED KINGDOM |

Abbott Laboratories Ltd

Queenborough

Kent

ME11 5EL

UNITED KINGDOM

EU/1/99/117/001-002

26.11.2009

24.11.2009

alli

| Glaxo Group Limited |
| --- |
| Berkeley Avenue |
| Greenford |
| Middlesex |
| UB6 0NN |
| UNITED KINGDOM |

Glaxo Group Limited

Berkeley Avenue

Greenford

Middlesex

UB6 0NN

UNITED KINGDOM

EU/1/07/401/007-010

26.11.2009

25.11.2009

Kivexa

| Glaxo Group Ltd |
| --- |
| Greenford |
| Middlesex |
| UB6 0NN |
| UNITED KINGDOM |

Glaxo Group Ltd

Greenford

Middlesex

UB6 0NN

UNITED KINGDOM

EU/1/04/298/001-003

27.11.2009

26.11.2009

Enbrel

| Wyeth Europa Limited |
| --- |
| Huntercombe Lane South |
| Taplow |
| Maidenhead |
| Berkshire |
| SL6 0PH |
| UNITED KINGDOM |

Wyeth Europa Limited

Huntercombe Lane South

Taplow

Maidenhead

Berkshire

SL6 0PH

UNITED KINGDOM

EU/1/99/126/001-021

1.12.2009

26.11.2009

Enbrel

| Wyeth Europa Limited |
| --- |
| Huntercombe Lane South |
| Taplow |
| Maidenhead |
| Berkshire |
| SL6 0PH |
| UNITED KINGDOM |

Wyeth Europa Limited

Huntercombe Lane South

Taplow

Maidenhead

Berkshire

SL6 0PH

UNITED KINGDOM

EU/1/99/126/001-021

1.12.2009

26.11.2009

Diacomit

| Biocodex |
| --- |
| 7 avenue Gallieni |
| 94250 Gentilly |
| FRANCE |

Biocodex

7 avenue Gallieni

94250 Gentilly

FRANCE

EU/1/06/367/001-012

1.12.2009

26.11.2009

Intelence

| Janssen-Cilag International NV |
| --- |
| Turnhoutseweg 30 |
| 2340 Beerse |
| BELGIË |

Janssen-Cilag International NV

Turnhoutseweg 30

2340 Beerse

BELGIË

EU/1/08/468/001

1.12.2009

26.11.2009

Abseamed

| Medice Arzneimittel Pütter GmbH & Co KG |
| --- |
| Kuhloweg 37 |
| 58638 Iserlohn |
| DEUTSCHLAND |

Medice Arzneimittel Pütter GmbH & Co KG

Kuhloweg 37

58638 Iserlohn

DEUTSCHLAND

EU/1/07/412/021-026

1.12.2009

27.11.2009

Pandemrix

| GlaxoSmithKline Biologicals S.A. |
| --- |
| Rue de l'Institut 89 |
| 1330 Rixensart |
| BELGIQUE |

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut 89

1330 Rixensart

BELGIQUE

EU/1/08/452/001

30.11.2009

27.11.2009

Focetria

| Novartis Vaccines and Diagnostics S.r.l. |
| --- |
| Via Fiorentina 1 |
| 53100 Siena SI |
| ITALIA |

Novartis Vaccines and Diagnostics S.r.l.

Via Fiorentina 1

53100 Siena SI

ITALIA

EU/1/07/385/001-002

EU/1/07/385/004

30.11.2009

30.11.2009

Velcade

| Janssen-Cilag International NV |
| --- |
| Turnhoutseweg 30 |
| 2340 Beerse |
| BELGIË |

Janssen-Cilag International NV

Turnhoutseweg 30

2340 Beerse

BELGIË

EU/1/04/274/001-002

2.12.2009

30.11.2009

Champix

| Pfizer Ltd |
| --- |
| Ramsgate Road |
| Sandwich |
| Kent |
| CT13 9NJ |
| UNITED KINGDOM |

Pfizer Ltd

Ramsgate Road

Sandwich

Kent

CT13 9NJ

UNITED KINGDOM

EU/1/06/360/001-013

2.12.2009

30.11.2009

Adcirca

| Eli Lilly Nederland B.V. |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| NEDERLAND |

Eli Lilly Nederland B.V.

Grootslag 1-5

3991 RA Houten

NEDERLAND

EU/1/08/476/001-006

2.12.2009

30.11.2009

Docetaxel Winthrop

| Aventis Pharma S.A. |
| --- |
| 20 avenue Raymond Aron |
| 92165 Antony Cedex |
| FRANCE |

Aventis Pharma S.A.

20 avenue Raymond Aron

92165 Antony Cedex

FRANCE

EU/1/07/384/003-004

2.12.2009

30.11.2009

Taxotere

| Aventis Pharma S.A. |
| --- |
| 20 avenue Raymond Aron |
| 92165 Antony Cedex |
| FRANCE |

Aventis Pharma S.A.

20 avenue Raymond Aron

92165 Antony Cedex

FRANCE

EU/1/95/002/003-004

2.12.2009

—   Withdrawal of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004)

| Date of the decision | Name of the medicinal product | Holder of the marketing authorisation | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 11.11.2009 | Irbesartan BMS | Bristol-Myers Squibb Pharma EEIG |
| Uxbridge Business Park |
| Sanderson Road |
| Uxbridge |
| UB8 1DH |
| UNITED KINGDOM |

Date of the decision

Name of the medicinal product

Holder of the marketing authorisation

Number of the entry in the Community Register

Date of notification

11.11.2009

Irbesartan BMS

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park

Sanderson Road

Uxbridge

UB8 1DH

UNITED KINGDOM

EU/1/06/375/001-033

13.11.2009

11.11.2009

Irbesartan HCT BMS

| Bristol-Myers Squibb Pharma EEIG |
| --- |
| Uxbridge Business Park |
| Sanderson Road |
| Uxbridge |
| UB8 1DH |
| UNITED KINGDOM |

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park

Sanderson Road

Uxbridge

UB8 1DH

UNITED KINGDOM

EU/1/06/369/001-028

13.11.2009

12.11.2009

Clopidogrel BMS

| Bristol-Myers Squibb Pharma EEIG |
| --- |
| Uxbridge Business Park |
| Sanderson Road |
| Uxbridge |
| UB8 1DH |
| UNITED KINGDOM |

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park

Sanderson Road

Uxbridge

UB8 1DH

UNITED KINGDOM

EU/1/08/464/001-019

17.11.2009

26.11.2009

Paxene

| Norton Healthcare Limited |
| --- |
| Albert Basin |
| Royal Docks |
| London |
| E16 2QJ |
| UNITED KINGDOM |

Norton Healthcare Limited

Albert Basin

Royal Docks

London

E16 2QJ

UNITED KINGDOM

EU/1/99/113/001-004

10.12.2009

—   Issuing of a marketing authorisation (Article 38 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | INN (International Non-Proprietary Name) | Holder of the marketing authorisation | Number of the entry in the Community Register | Pharmaceutical form | ATC code (Anatomical Therapeutic Chemical Code) | Date of notification |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 4.11.2009 | Zolvix | Monepantel | Novartis Healthcare A/S |
| Lyngbyvej 172 |
| 2100 Copenhagen |
| DANMARK |

Date of the decision

Name of the medicinal product

INN (International Non-Proprietary Name)

Holder of the marketing authorisation

Number of the entry in the Community Register

Pharmaceutical form

ATC code (Anatomical Therapeutic Chemical Code)

Date of notification

4.11.2009

Zolvix

Monepantel

Novartis Healthcare A/S

Lyngbyvej 172

2100 Copenhagen

DANMARK

EU/2/09/101/001-010

Oral solution

QP52AX09

6.11.2009

—   Modification of a marketing authorisation (Article 38 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorisation | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 18.11.2009 | Dexdomitor | Orion Corporation |
| Orionintie 1 |
| FI-02200 Espoo |
| SUOMI/FINLAND |

Date of the decision

Name of the medicinal product

Holder of the marketing authorisation

Number of the entry in the Community Register

Date of notification

18.11.2009

Dexdomitor

Orion Corporation

Orionintie 1

FI-02200 Espoo

SUOMI/FINLAND

EU/2/02/033/001-002

20.11.2009

19.11.2009

Improvac

| Pfizer Limited |
| --- |
| Ramsgate Road |
| Sandwich |
| Kent |
| CT13 9NJ |
| UNITED KINGDOM |

Pfizer Limited

Ramsgate Road

Sandwich

Kent

CT13 9NJ

UNITED KINGDOM

EU/2/09/095/001-003

23.11.2009

20.11.2009

Metacam

| Boehringer Ingelheim Vetmedica GmbH |
| --- |
| 55216 Ingelheim am Rhein |
| DEUTSCHLAND |

Boehringer Ingelheim Vetmedica GmbH

55216 Ingelheim am Rhein

DEUTSCHLAND

EU/2/97/004/026

EU/2/97/004/033-034

24.11.2009

23.11.2009

Halocur

| Intervet International B.V. |
| --- |
| Wim de Körverstraat 35 |
| 5831 AN Boxmeer |
| NEDERLAND |

Intervet International B.V.

Wim de Körverstraat 35

5831 AN Boxmeer

NEDERLAND

EU/2/99/013/001-002

25.11.2009

Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

| The European Medicines Agency |
| --- |
| 7 Westferry Circus |
| Canary Wharf |
| London |
| E14 4HB |
| UNITED KINGDOM |

The European Medicines Agency

7 Westferry Circus

Canary Wharf

London

E14 4HB

UNITED KINGDOM

---

(1)  OJ L 136, 30.4.2004, p. 1.

---

| 29.1.2010 | EN | Official Journal of the European Union | C 22/13 |
| --- | --- | --- | --- |

29.1.2010

EN

Official Journal of the European Union

C 22/13

---

Summary of Community decisions on marketing authorisations in respect of medicinal products from 1 November 2009 to 30 November 2009

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council
   (1)
  or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council
   (2)
  )

2010/C 22/03

—   Issuing, maintenance or modification of a national marketing authorisation

| Date of the decision | Name(s) of the medicinal product | Holder(s) of the marketing authorisation | Member State concerned | Date of notification |
| --- | --- | --- | --- | --- |
| 6.11.2009 | Arimidex | See Annex | See Annex | 9.11.2009 |
| 26.11.2009 | Multaq | Sanofi-Aventis |
| 174 avenue de France |
| 75013 Paris |
| FRANCE |

Date of the decision

Name(s) of the medicinal product

Holder(s) of the marketing authorisation

Member State concerned

Date of notification

6.11.2009

Arimidex

See Annex

See Annex

9.11.2009

26.11.2009

Multaq

Sanofi-Aventis

174 avenue de France

75013 Paris

FRANCE

This Decision is addressed to the Member States

30.11.2009

---

(1)  OJ L 311, 28.11.2001, p. 67.

(2)  OJ L 311, 28.11.2001, p. 1.

---

ANNEX

LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCT, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES

| Member State (EU/EEA) | Marketing Authorisation Holder | Invented name | Strength | Pharmaceutical form | Route of administration |
| --- | --- | --- | --- | --- | --- |
| Austria | AstraZeneca Ősterreich GmbH |
| Schwarzenbergplatz 7 |
| 1037 Wien |
| ÖSTERREICH |

Member State (EU/EEA)

Marketing Authorisation Holder

Invented name

Strength

Pharmaceutical form

Route of administration

Austria

AstraZeneca Ősterreich GmbH

Schwarzenbergplatz 7

1037 Wien

ÖSTERREICH

Arimidex

1 mg

Film-coated tablets

Oral

Belgium

| NV AstraZeneca SA |
| --- |
| Egide Van Ophemstraat |
| 1180 Brussel |
| BELGIË |

NV AstraZeneca SA

Egide Van Ophemstraat

1180 Brussel

BELGIË

Arimidex

1 mg

Film-coated tablets

Oral

Bulgaria

| AstraZeneca Pharmaceuticals AB |
| --- |
| SE-151 85 Södertälje |
| SVERIGE |

AstraZeneca Pharmaceuticals AB

SE-151 85 Södertälje

SVERIGE

Arimidex

1 mg

Film-coated tablets

Oral

Cyprus

| AstraZeneca UK LTD |
| --- |
| Silk Road Business Park |
| Macclesfield |
| Cheshire |
| SK10 2NA |
| UNITED KINGDOM |

AstraZeneca UK LTD

Silk Road Business Park

Macclesfield

Cheshire

SK10 2NA

UNITED KINGDOM

Arimidex

1 mg

Film-coated tablets

Oral

Czech Republic

| AstraZeneca UK Ltd |
| --- |
| Silk Road Business Park |
| Macclesfield |
| Cheshire |
| SK10 2NA |
| UNITED KINGDOM |

AstraZeneca UK Ltd

Silk Road Business Park

Macclesfield

Cheshire

SK10 2NA

UNITED KINGDOM

Arimidex

1 mg

Film-coated tablets

Oral

Denmark

| AstraZeneca A/S |
| --- |
| Roskildevej 22 |
| 2620 Albertslund |
| DANMARK |

AstraZeneca A/S

Roskildevej 22

2620 Albertslund

DANMARK

Arimidex

1 mg

Film-coated tablets

Oral

Estonia

| AstraZeneca UK Ltd |
| --- |
| 15 Stanhope Gate |
| London |
| W1K 1LN |
| UNITED KINGDOM |

AstraZeneca UK Ltd

15 Stanhope Gate

London

W1K 1LN

UNITED KINGDOM

Arimidex

1 mg

Film-coated tablets

Oral

Finland

| AstraZeneca Oy Luomanportti 3 |
| --- |
| FI-02200 Espoo |
| SUOMI/FINLAND |

AstraZeneca Oy Luomanportti 3

FI-02200 Espoo

SUOMI/FINLAND

Arimidex

1 mg

Film-coated tablets

Oral

France

| AstraZeneca |
| --- |
| 1 place Renault |
| 92844 Rueil-Malmaison Cedex |
| FRANCE |

AstraZeneca

1 place Renault

92844 Rueil-Malmaison Cedex

FRANCE

Arimidex

1 mg

Film-coated tablets

Oral

Germany

| AstraZeneca GmbH |
| --- |
| 22876 Wedel |
| DEUTSCHLAND |

AstraZeneca GmbH

22876 Wedel

DEUTSCHLAND

Arimidex

1 mg

Film-coated tablets

Oral

Greece

| AstraZeneca S.A. |
| --- |
| Theotokopoulou & Astronafton str 4 |
| 151 25 Maroussi Athens |
| GREECE |

AstraZeneca S.A.

Theotokopoulou & Astronafton str 4

151 25 Maroussi Athens

GREECE

Arimidex

1 mg

Film-coated tablets

Oral

Hungary

| AstraZeneca Kft. |
| --- |
| Törökbálint |
| Park u. 3. |
| 2045 |
| MAGYARORSZÁG/HUNGARY |

AstraZeneca Kft.

Törökbálint

Park u. 3.

2045

MAGYARORSZÁG/HUNGARY

Arimidex

1 mg

Film-coated tablets

Oral

Iceland

| AstraZeneca UK Ltd |
| --- |
| Silk Road Business Park |
| Macclesfield |
| Cheshire |
| SK10 2NA |
| UNITED KINGDOM |

AstraZeneca UK Ltd

Silk Road Business Park

Macclesfield

Cheshire

SK10 2NA

UNITED KINGDOM

Arimidex

1 mg

Film-coated tablets

Oral

Ireland

| AstraZeneca UK Limited |
| --- |
| 600 Capability Green |
| Luton |
| LU1 3LU |
| UNITED KINGDOM |

AstraZeneca UK Limited

600 Capability Green

Luton

LU1 3LU

UNITED KINGDOM

Arimidex

1 mg

Film-coated tablets

Oral

Italy

| AstraZeneca S.p.A. |
| --- |
| Palazzo Volta |
| Via F. Sforza |
| 20080 Basiglio Milano MI |
| ITALIA |

AstraZeneca S.p.A.

Palazzo Volta

Via F. Sforza

20080 Basiglio Milano MI

ITALIA

Arimidex

1 mg

Film-coated tablets

Oral

Latvia

| AstraZeneca UK Limited |
| --- |
| Silk Road Business Park |
| Macclesfield |
| Cheshire |
| SK10 2NA |
| UNITED KINGDOM |

AstraZeneca UK Limited

Silk Road Business Park

Macclesfield

Cheshire

SK10 2NA

UNITED KINGDOM

Arimidex

1 mg

Film-coated tablets

Oral

Lithuania

| AstraZeneca UK Limited |
| --- |
| Silk Road Business Park |
| Macclesfield |
| Cheshire |
| SK10 2NA |
| UNITED KINGDOM |

AstraZeneca UK Limited

Silk Road Business Park

Macclesfield

Cheshire

SK10 2NA

UNITED KINGDOM

Arimidex

1 mg

Film-coated tablets

Oral

Luxembourg

| NV AstraZeneca SA |
| --- |
| Rue Egide Van Ophem |
| 1180 Bruxelles |
| BELGIQUE |

NV AstraZeneca SA

Rue Egide Van Ophem

1180 Bruxelles

BELGIQUE

Arimidex

1 mg

Film-coated tablets

Oral

Malta

| AstraZeneca UK Limited |
| --- |
| Silk Road Business Park |
| Macclesfield |
| Cheshire |
| SK10 2NA |
| UNITED KINGDOM |

AstraZeneca UK Limited

Silk Road Business Park

Macclesfield

Cheshire

SK10 2NA

UNITED KINGDOM

Arimidex

1 mg

Film-coated tablets

Oral

Netherlands

| AstraZeneca BV |
| --- |
| Louis Pasteurlaan 5 |
| 2719 EE Zoetermeer |
| NEDERLAND |

AstraZeneca BV

Louis Pasteurlaan 5

2719 EE Zoetermeer

NEDERLAND

Arimidex

1 mg

Film-coated tablets

Oral

Norway

| AstraZeneca AS |
| --- |
| Hoffsveien 70B |
| Box 200 Vinderen |
| 0319 Oslo |
| NORWAY |

AstraZeneca AS

Hoffsveien 70B

Box 200 Vinderen

0319 Oslo

NORWAY

Arimidex

1 mg

Film-coated tablets

Oral

Poland

| AstraZeneca UK Limited |
| --- |
| Silk Road Business Park |
| Macclesfield |
| Cheshire |
| SK10 2NA |
| UNITED KINGDOM |

AstraZeneca UK Limited

Silk Road Business Park

Macclesfield

Cheshire

SK10 2NA

UNITED KINGDOM

Arimidex

1 mg

Film-coated tablets

Oral

Portugal

| AstraZeneca Produtos Farmacêuticos, Lda. |
| --- |
| Rua Humberto Madeira 7 |
| Valejas |
| 2745-663 Barcarena |
| PORTUGAL |

AstraZeneca Produtos Farmacêuticos, Lda.

Rua Humberto Madeira 7

Valejas

2745-663 Barcarena

PORTUGAL

Arimidex

1 mg

Film-coated tablets

Oral

Romania

| AstraZeneca UK Limited |
| --- |
| 600 Capability Green |
| Luton |
| LU1 3LU |
| UNITED KINGDOM |

AstraZeneca UK Limited

600 Capability Green

Luton

LU1 3LU

UNITED KINGDOM

Arimidex

1 mg

Film-coated tablets

Oral

Slovakia

| AstraZeneca UK Limited |
| --- |
| Silk Road Business Park |
| Macclesfield |
| Cheshire |
| SK10 2NA |
| UNITED KINGDOM |

AstraZeneca UK Limited

Silk Road Business Park

Macclesfield

Cheshire

SK10 2NA

UNITED KINGDOM

Arimidex

1 mg

Film-coated tablets

Oral

Slovenia

| AstraZeneca UK Limited |
| --- |
| 15 Stanhope Gate |
| London |
| W1K 1LN |
| UNITED KINGDOM |

AstraZeneca UK Limited

15 Stanhope Gate

London

W1K 1LN

UNITED KINGDOM

Arimidex 1 mg film-coated tablets

1 mg

Film-coated tablets

Oral

Spain

| AstraZeneca Farmacéutica Spain, S.A. |
| --- |
| Parque Norte |
| Edificio Roble |
| C/ Serrano Galvache, 56 |
| 28033 Madrid |
| ESPAÑA |

AstraZeneca Farmacéutica Spain, S.A.

Parque Norte

Edificio Roble

C/ Serrano Galvache, 56

28033 Madrid

ESPAÑA

Arimidex

1 mg

Film-coated tablets

Oral

Sweden

| AstraZeneca AB |
| --- |
| SE-151 85 Södertälje |
| SVERIGE |

AstraZeneca AB

SE-151 85 Södertälje

SVERIGE

Arimidex

1 mg

Film-coated tablets

Oral

United Kingdom

| AstraZeneca UK Limited |
| --- |
| 600 Capability Green |
| Luton |
| LU1 3LU |
| UNITED KINGDOM |

AstraZeneca UK Limited

600 Capability Green

Luton

LU1 3LU

UNITED KINGDOM

Arimidex

1 mg

Film-coated tablets

Oral

---

| 29.1.2010 | EN | Official Journal of the European Union | C 22/18 |
| --- | --- | --- | --- |

29.1.2010

EN

Official Journal of the European Union

C 22/18

---

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 December 2009 to 31 December 2009

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
   (1)
  )

2010/C 22/04

—   Issuing of a marketing authorization (Article 13 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | INN (International Non-Proprietary Name) | Holder of the marketing authorization | Number of the entry in the Community Register | Pharmaceutical form | ATC code (Anatomical Therapeutic Chemical Code) | Date of notification |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 3.12.2009 | Olanzapine Glenmark Europe | Olanzapine | Glenmark Generics (Europe) Limited |
| Laxmi House |
| 2-B Draycott Avenue |
| Kenton |
| Harrow |
| Middlesex |
| HA3 OBU |
| UNITED KINGDOM |

Date of the decision

Name of the medicinal product

INN (International Non-Proprietary Name)

Holder of the marketing authorization

Number of the entry in the Community Register

Pharmaceutical form

ATC code (Anatomical Therapeutic Chemical Code)

Date of notification

3.12.2009

Olanzapine Glenmark Europe

Olanzapine

Glenmark Generics (Europe) Limited

Laxmi House

2-B Draycott Avenue

Kenton

Harrow

Middlesex

HA3 OBU

UNITED KINGDOM

EU/1/09/588/001-017

Orodispersible tablet

N05AH03

7.12.2009

3.12.2009

Olanzapine Glenmark

Olanzapine

| Glenmark Generics (Europe) Limited |
| --- |
| Laxmi House |
| 2-B Draycott Avenue |
| Kenton |
| Harrow |
| Middlesex |
| HA3 OBU |
| UNITED KINGDOM |

Glenmark Generics (Europe) Limited

Laxmi House

2-B Draycott Avenue

Kenton

Harrow

Middlesex

HA3 OBU

UNITED KINGDOM

EU/1/09/587/001-012

Tablet

N05AH03

7.12.2009

9.12.2009

Prevenar 13

Pneumococcalpolysaccharide conjugate vaccine (13-valent, adsorbed)

| Wyeth Lederle Vaccines S.A. |
| --- |
| Rue du Bosquet 15 |
| 1348 Louvain-la-Neuve |
| BELGIQUE |

Wyeth Lederle Vaccines S.A.

Rue du Bosquet 15

1348 Louvain-la-Neuve

BELGIQUE

EU/1/09/590/001-006

Suspension for injection

J07AL02

11.12.2009

10.12.2009

Lamivudine Teva Pharma B.V

Lamivudine

| Teva Pharma B.V. |
| --- |
| Computerweg 10 |
| 3542 DR Utrecht |
| NEDERLAND |

Teva Pharma B.V.

Computerweg 10

3542 DR Utrecht

NEDERLAND

EU/1/09/596/001-014

Film-coated tablet

J05AF05

14.12.2009

10.12.2009

Olazax Disperzi

Olanzapine

| Glenmark Pharmaceuticals s.r.o |
| --- |
| City Tower |
| Hvězdova 1716/2b |
| 140 78 Praha 4 |
| ČESKÁ REPUBLIKA |

Glenmark Pharmaceuticals s.r.o

City Tower

Hvězdova 1716/2b

140 78 Praha 4

ČESKÁ REPUBLIKA

EU/1/09/592/001-005

Orodispersible tablet

N05AH03

14.12.2009

10.12.2009

Sildenafil Actavis

Sildenafil

| Actavis Group PTC ehf. |
| --- |
| Reykjavikurvegi 76-78 |
| 220 Hafnarfjordur |
| ICELAND |

Actavis Group PTC ehf.

Reykjavikurvegi 76-78

220 Hafnarfjordur

ICELAND

EU/1/09/595/001-015

Film-coated tablet

G04BE03

14.12.2009

11.12.2009

Olazax

Olanzapine

| Glenmark Pharmaceuticals s.r.o. |
| --- |
| City Tower |
| Hvězdova 1716/2b |
| 140 78 Praha 4 |
| ČESKÁ REPUBLIKA |

Glenmark Pharmaceuticals s.r.o.

City Tower

Hvězdova 1716/2b

140 78 Praha 4

ČESKÁ REPUBLIKA

EU/1/09/597/001-005

Tablet

N05AH03

15.12.2009

11.12.2009

Rivastigmine Hexal

Rivastigmine

| HEXAL AG |
| --- |
| Industriestrasse 25 |
| 83607 Holzkirchen |
| DEUTSCHLAND |

HEXAL AG

Industriestrasse 25

83607 Holzkirchen

DEUTSCHLAND

EU/1/09/589/001-016

EU/1/09/589/017-018

Capsule, hard

Oral solution

N06DA03

15.12.2009

11.12.2009

Rivastigmine Sandoz

Rivastigmine

| Sandoz Pharmaceuticals GmbH |
| --- |
| Raiffeisenstraße 11 |
| 83607 Holzkirchen |
| DEUTSCHLAND |

Sandoz Pharmaceuticals GmbH

Raiffeisenstraße 11

83607 Holzkirchen

DEUTSCHLAND

EU/1/09/599/001-016

EU/1/09/599/017-018

Capsule, hard

Oral solution

N06DA03

15.12.2009

23.12.2009

Zenas

Amifampridine

| EUSA Pharma SAS |
| --- |
| 3 allée des Séquoias |
| 69760 Limonest |
| FRANCE |

EUSA Pharma SAS

3 allée des Séquoias

69760 Limonest

FRANCE

EU/1/09/601/001

Tablet

N07XX05

28.12.2009

23.12.2009

Sildenafil ratiopharm

Sildenafil

| Ratiopharm GmbH |
| --- |
| Graf-Arco-Straße 3 |
| 89079 Ulm |
| DEUTSCHLAND |

Ratiopharm GmbH

Graf-Arco-Straße 3

89079 Ulm

DEUTSCHLAND

EU/1/09/603/001-012

Film-coated tablet

G04BE03

28.12.2009

—   Modification of a marketing authorization (Article 13 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 3.12.2009 | Champix | Pfizer Ltd. |
| Ramsgate Road |
| Sandwich |
| Kent |
| CT13 9NJ |
| UNITED KINGDOM |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

3.12.2009

Champix

Pfizer Ltd.

Ramsgate Road

Sandwich

Kent

CT13 9NJ

UNITED KINGDOM

EU/1/06/360/001-013

7.12.2009

3.12.2009

Rasilez

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex |
| RH12 5AB |
| UNITED KINGDOM |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex

RH12 5AB

UNITED KINGDOM

EU/1/07/405/001-040

7.12.2009

8.12.2009

Xigiris

| Eli Lilly Nederland B.V. |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| NEDERLAND |

Eli Lilly Nederland B.V.

Grootslag 1-5

3991 RA Houten

NEDERLAND

EU/1/02/225/001-002

10.12.2009

8.12.2009

Renagel

| Genzyme Europe B.V. |
| --- |
| Gooimeer 10 |
| 1411 DD Naarden |
| NEDERLAND |

Genzyme Europe B.V.

Gooimeer 10

1411 DD Naarden

NEDERLAND

EU/1/99/123/005-013

10.12.2009

9.12.2009

Stocrin

| Merck Sharp & Dohme Ltd. |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire |
| EN11 9BU |
| UNITED KINGDOM |

Merck Sharp & Dohme Ltd.

Hertford Road

Hoddesdon

Hertfordshire

EN11 9BU

UNITED KINGDOM

EU/1/99/111/001-005

EU/1/99/111/008-011

11.12.2009

9.12.2009

Sustiva

| Bristol-Myers Squibb Pharma EEIG |
| --- |
| Uxbridge Business Park |
| Sanderson Road |
| Uxbridge |
| UB8 1DH |
| UNITED KINGDOM |

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park

Sanderson Road

Uxbridge

UB8 1DH

UNITED KINGDOM

EU/1/99/110/001-005

EU/1/99/110/008-010

11.12.2009

9.12.2009

Pandemrix

| GlaxoSmithKline Biologicals S.A. |
| --- |
| Rue de l'Institut 89 |
| 1330 Rixensart |
| BELGIQUE |

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut 89

1330 Rixensart

BELGIQUE

EU/1/08/452/001

11.12.2009

10.12.2009

Effentora

| Cephalon Europe |
| --- |
| 5 rue Charles Martigny |
| 94700 Maisons-Alfort |
| FRANCE |

Cephalon Europe

5 rue Charles Martigny

94700 Maisons-Alfort

FRANCE

EU/1/08/441/001-010

14.12.2009

10.12.2009

Effentora

| Cephalon Europe |
| --- |
| 5 rue Charles Martigny |
| 94700 Maisons-Alfort |
| FRANCE |

Cephalon Europe

5 rue Charles Martigny

94700 Maisons-Alfort

FRANCE

EU/1/08/441/001-010

14.12.2009

10.12.2009

Synflorix

| GlaxoSmithKline Biologicals S.A. |
| --- |
| Rue de l'Institut 89 |
| 1330 Rixensart |
| BELGIQUE |

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut 89

1330 Rixensart

BELGIQUE

EU/1/09/508/001-010

14.12.2009

10.12.2009

Truvada

| Gilead Sciences International Limited |
| --- |
| Cambridge |
| CB21 6GT |
| UNITED KINGDOM |

Gilead Sciences International Limited

Cambridge

CB21 6GT

UNITED KINGDOM

EU/1/04/305/001-002

14.12.2009

10.12.2009

Fendrix

| GlaxoSmithKline Biologicals S.A. |
| --- |
| Rue de l'Institut 89 |
| 1330 Rixensart |
| BELGIQUE |

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut 89

1330 Rixensart

BELGIQUE

EU/1/04/299/001-003

14.12.2009

10.12.2009

EVOLTRA

| Genzyme Europe B.V. |
| --- |
| Gooimeer 10 |
| 1411 DD Naarden |
| NEDERLAND |

Genzyme Europe B.V.

Gooimeer 10

1411 DD Naarden

NEDERLAND

EU/1/06/334/001-005

14.12.2009

10.12.2009

Revatio

| Pfizer Limited |
| --- |
| Sandwich |
| Kent |
| CT13 9NJ |
| UNITED KINGDOM |

Pfizer Limited

Sandwich

Kent

CT13 9NJ

UNITED KINGDOM

EU/1/05/318/002

24.12.2009

11.12.2009

Kivexa

| Glaxo Group Ltd. |
| --- |
| Greenford |
| Middlesex |
| UB6 0NN |
| UNITED KINGDOM |

Glaxo Group Ltd.

Greenford

Middlesex

UB6 0NN

UNITED KINGDOM

EU/1/04/298/001-003

16.12.2009

11.12.2009

Clopidogrel Mylan Pharma

| Apotex Europe B.V. |
| --- |
| Darwingweg 20 |
| 2333 CR Leiden |
| NEDERLAND |

Apotex Europe B.V.

Darwingweg 20

2333 CR Leiden

NEDERLAND

| Mylan S.A.S. |
| --- |
| 117 allée des Parcs |
| 69800 Saint Priest |
| FRANCE |

Mylan S.A.S.

117 allée des Parcs

69800 Saint Priest

FRANCE

EU/1/09/568/001-018

16.12.2009

11.12.2009

Rivastigmine 1A Pharma

| 1A Pharma GmbH |
| --- |
| Keltenring 1+3 |
| 82041 Oberhaching |
| DEUTSCHLAND |

1A Pharma GmbH

Keltenring 1+3

82041 Oberhaching

DEUTSCHLAND

EU/1/09/585/001-018

16.12.2009

11.12.2009

EVICEL

| OMRIX biopharmaceuticals S.A./N.V. |
| --- |
| Chaussée de Waterloo/Waterloosesteenweg 200 |
| 1640 Rhode-St-Genèse/Sint-Genesius-Rode |
| BELGIQUE/BELGIË |

OMRIX biopharmaceuticals S.A./N.V.

Chaussée de Waterloo/Waterloosesteenweg 200

1640 Rhode-St-Genèse/Sint-Genesius-Rode

BELGIQUE/BELGIË

EU/1/08/473/001-003

15.12.2009

11.12.2009

Abseamed

| Medice Arzneimittel Pütter GmbH & Co KG |
| --- |
| Kuhloweg 37 |
| 58638 Iserlohn |
| DEUTSCHLAND |

Medice Arzneimittel Pütter GmbH & Co KG

Kuhloweg 37

58638 Iserlohn

DEUTSCHLAND

EU/1/07/412/001-020

15.12.2009

14.12.2009

Efient

| Eli Lilly Nederland B.V. |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| NEDERLAND |

Eli Lilly Nederland B.V.

Grootslag 1-5

3991 RA Houten

NEDERLAND

EU/1/08/503/001-016

16.12.2009

14.12.2009

Exalief

| BIAL-Portela & Ca, SA |
| --- |
| A Av. da Siderurgia Nacional |
| 4745-457 S. Mamede do Coronado |
| PORTUGAL |

BIAL-Portela & Ca, SA

A Av. da Siderurgia Nacional

4745-457 S. Mamede do Coronado

PORTUGAL

EU/1/09/520/001-020

17.12.2009

14.12.2009

Zebinix

| BIAL-Portela & Ca, SA |
| --- |
| A Av. da Siderurgia Nacional |
| 4745-457 S. Mamede do Coronado |
| PORTUGAL |

BIAL-Portela & Ca, SA

A Av. da Siderurgia Nacional

4745-457 S. Mamede do Coronado

PORTUGAL

EU/1/09/514/001-020

17.12.2009

16.12.2009

REVLIMID

| Celgene Europe Limited |
| --- |
| Riverside House |
| Riverside Walk |
| Windsor |
| Berkshire |
| SL4 1NA |
| UNITED KINGDOM |

Celgene Europe Limited

Riverside House

Riverside Walk

Windsor

Berkshire

SL4 1NA

UNITED KINGDOM

EU/1/07/391/001-004

18.12.2009

18.12.2009

Docetaxel Winthrop

| Aventis Pharma S.A. |
| --- |
| 20 avenue Raymond Aron |
| 92165 Antony Cedex |
| FRANCE |

Aventis Pharma S.A.

20 avenue Raymond Aron

92165 Antony Cedex

FRANCE

EU/1/07/384/001-004

22.12.2009

18.12.2009

Emtriva

| Gilead Sciences International Limited |
| --- |
| Cambridge |
| CB21 6GT |
| UNITED KINGDOM |

Gilead Sciences International Limited

Cambridge

CB21 6GT

UNITED KINGDOM

EU/1/03/261/003

22.12.2009

18.12.2009

Adenuric

| Ipsen Pharma |
| --- |
| 65 quai Georges Gorse |
| 92100 Boulogne-Billancourt |
| FRANCE |

Ipsen Pharma

65 quai Georges Gorse

92100 Boulogne-Billancourt

FRANCE

| Menarini International Operations Luxembourg S.A. |
| --- |
| 1, avenue de la Gare |
| 1611 Luxembourg |
| LUXEMBOURG |

Menarini International Operations Luxembourg S.A.

1, avenue de la Gare

1611 Luxembourg

LUXEMBOURG

EU/1/08/447/001-004

22.12.2009

18.12.2009

Aloxi

| Helsinn Birex Pharmaceuticals Ltd. |
| --- |
| Damastown |
| Mulhuddart |
| Dublin 15 |
| IRELAND |

Helsinn Birex Pharmaceuticals Ltd.

Damastown

Mulhuddart

Dublin 15

IRELAND

EU/1/04/306/001

22.12.2009

16.12.2009

Binocrit

| Sandoz GmbH |
| --- |
| Biochemiestraße 10 |
| 6250 Kundl |
| ÖSTERREICH |

Sandoz GmbH

Biochemiestraße 10

6250 Kundl

ÖSTERREICH

EU/1/07/410/001-026

18.12.2009

16.12.2009

Epoetin alfa hexal

| Hexal AG. |
| --- |
| Industriestraße 25 |
| 83607 Holzkirchen |
| DEUTSCHLAND |

Hexal AG.

Industriestraße 25

83607 Holzkirchen

DEUTSCHLAND

EU/1/07/411/001-026

21.12.2009

16.12.2009

Silapo

| STADA Arzneimittel AG |
| --- |
| Stadastraße 2—18 |
| 61118 Bad Vilbel |
| DEUTSCHLAND |

STADA Arzneimittel AG

Stadastraße 2—18

61118 Bad Vilbel

DEUTSCHLAND

EU/1/07/432/001-022

18.12.2009

18.12.2009

Litak

| Lipomed GmbH |
| --- |
| Hegenheimer Straße 2 |
| 79576 Weil/Rhein |
| DEUTSCHLAND |

Lipomed GmbH

Hegenheimer Straße 2

79576 Weil/Rhein

DEUTSCHLAND

EU/1/04/275/001-002

22.12.2009

21.12.2009

AZARGA

| Alcon Laboratories (UK) Ltd. |
| --- |
| Pentagon Park |
| Boundary Way |
| Hemel Hempstead |
| Herts |
| HP2 7UD |
| UNITED KINGDOM |

Alcon Laboratories (UK) Ltd.

Pentagon Park

Boundary Way

Hemel Hempstead

Herts

HP2 7UD

UNITED KINGDOM

EU/1/08/482/001-002

23.12.2009

21.12.2009

Altargo

| Glaxo Group Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex |
| UB6 0NN |
| UNITED KINGDOM |

Glaxo Group Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex

UB6 0NN

UNITED KINGDOM

EU/1/07/390/001-004

24.12.2009

21.12.2009

Zyprexa Velotab

| Eli Lilly Nederland B.V. |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| NEDERLAND |

Eli Lilly Nederland B.V.

Grootslag 1-5

3991 RA Houten

NEDERLAND

EU/1/99/125/001-016

23.12.2009

21.12.2009

Avastin

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City |
| AL7 1TW |
| UNITED KINGDOM |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City

AL7 1TW

UNITED KINGDOM

EU/1/04/300/001-002

23.12.2009

21.12.2009

LYRICA

| Pfizer Ltd. |
| --- |
| Ramsgate Road |
| Sandwich |
| Kent |
| CT13 9NJ |
| UNITED KINGDOM |

Pfizer Ltd.

Ramsgate Road

Sandwich

Kent

CT13 9NJ

UNITED KINGDOM

EU/1/04/279/001-043

24.12.2009

21.12.2009

Taxotere

| Aventis Pharma S.A. |
| --- |
| 20 avenue Raymond Aron |
| 92165 Antony Cedex |
| FRANCE |

Aventis Pharma S.A.

20 avenue Raymond Aron

92165 Antony Cedex

FRANCE

EU/1/95/002/001-004

23.12.2009

21.12.2009

Zyprexa

| Eli Lilly Nederland B.V. |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| NEDERLAND |

Eli Lilly Nederland B.V.

Grootslag 1-5

3991 RA Houten

NEDERLAND

EU/1/96/022/002

EU/1/96/022/004

EU/1/96/022/006

EU/1/96/022/009-012

EU/1/96/022/014

EU/1/96/022/016-017

EU/1/96/022/019-034

23.12.2009

21.12.2009

Revasc

| Canyon Pharmaceuticals Ltd. |
| --- |
| 20-22 Bedford Row |
| London |
| WC1R 4JS |
| UNITED KINGDOM |

Canyon Pharmaceuticals Ltd.

20-22 Bedford Row

London

WC1R 4JS

UNITED KINGDOM

EU/1/97/043/001-003

11.1.2010

21.12.2009

RAPAMUNE

| Wyeth Europa Limited |
| --- |
| Huntercombe Lane South |
| Taplow |
| Maidenhead |
| Berkshire |
| SL6 0PH |
| UNITED KINGDOM |

Wyeth Europa Limited

Huntercombe Lane South

Taplow

Maidenhead

Berkshire

SL6 0PH

UNITED KINGDOM

EU/1/01/171/001

EU/1/01/171/007-010

23.12.2009

21.12.2009

SOLIRIS

| Alexion Europe S.A.S. |
| --- |
| 25 Boulevard de l'Amiral Bruix |
| 75016 Paris |
| FRANCE |

Alexion Europe S.A.S.

25 Boulevard de l'Amiral Bruix

75016 Paris

FRANCE

EU/1/07/393/001

23.12.2009

21.12.2009

Vimpat

| UCB Pharma SA. |
| --- |
| Allée de la Recherche 66/Researchdreef 60 |
| 1070 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

UCB Pharma SA.

Allée de la Recherche 66/Researchdreef 60

1070 Bruxelles/Brussel

BELGIQUE/BELGIË

EU/1/08/470/001-017

28.12.2009

21.12.2009

ZONEGRAN

| Eisai Limited |
| --- |
| European Knowledge Centre |
| Mosquito Way |
| Hatfield |
| Hertfordshire |
| AL10 9SN |
| UNITED KINGDOM |

Eisai Limited

European Knowledge Centre

Mosquito Way

Hatfield

Hertfordshire

AL10 9SN

UNITED KINGDOM

EU/1/04/307/001-013

24.12.2009

21.12.2009

ZYPADHERA

| Eli Lilly Nederland B.V. |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| NEDERLAND |

Eli Lilly Nederland B.V.

Grootslag 1-5

3991 RA Houten

NEDERLAND

EU/1/08/479/001-003

23.12.2009

21.12.2009

Agenerase

| Glaxo Group Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex |
| UB6 0NN |
| UNITED KINGDOM |

Glaxo Group Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex

UB6 0NN

UNITED KINGDOM

EU/1/00/148/001-004

23.12.2009

21.12.2009

Irbesartan HCT Winthrop

| Sanofi Pharma Bristol Myers Squibb SNC |
| --- |
| 174 avenue de France |
| 75013 Paris |
| FRANCE |

Sanofi Pharma Bristol Myers Squibb SNC

174 avenue de France

75013 Paris

FRANCE

EU/1/06/377/001-028

23.12.2009

21.12.2009

KARVEZIDE

| Bristol-Myers Squibb Pharma EEIG |
| --- |
| Uxbridge Business Park |
| Sanderson Road |
| Uxbridge |
| UB8 1DH |
| UNITED KINGDOM |

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park

Sanderson Road

Uxbridge

UB8 1DH

UNITED KINGDOM

EU/1/98/085/001-034

23.12.2009

21.12.2009

Tevagrastim

| Teva Generics GmbH |
| --- |
| Wasastraße 50 |
| 01445 Radebeul |
| DEUTSCHLAND |

Teva Generics GmbH

Wasastraße 50

01445 Radebeul

DEUTSCHLAND

EU/1/08/445/001-014

23.12.2009

21.12.2009

Avamys

| Glaxo Group Ltd. |
| --- |
| Greenford |
| Middlesex |
| UB6 0NN |
| UNITED KINGDOM |

Glaxo Group Ltd.

Greenford

Middlesex

UB6 0NN

UNITED KINGDOM

EU/1/07/434/001-003

24.12.2009

21.12.2009

Thelin

| Encysive (UK) Limited |
| --- |
| Alder Castle House |
| 10 Noble Street |
| London |
| EC2V 7QJ |
| UNITED KINGDOM |

Encysive (UK) Limited

Alder Castle House

10 Noble Street

London

EC2V 7QJ

UNITED KINGDOM

EU/1/06/353/001-005

24.12.2009

21.12.2009

Volibris

| Glaxo Group Ltd. |
| --- |
| Greenford |
| Middlesex |
| UB6 0NN |
| UNITED KINGDOM |

Glaxo Group Ltd.

Greenford

Middlesex

UB6 0NN

UNITED KINGDOM

EU/1/08/451/001-004

24.12.2009

22.12.2009

CELVAPAN

| Baxter AG |
| --- |
| Industriestraße 67 |
| 1221 Wien |
| ÖSTERREICH |

Baxter AG

Industriestraße 67

1221 Wien

ÖSTERREICH

EU/1/08/506/001

23.12.2009

22.12.2009

Pandemrix

| GlaxoSmithKline Biologicals S.A. |
| --- |
| Rue de l'Institut 89 |
| 1330 Rixensart |
| BELGIQUE |

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut 89

1330 Rixensart

BELGIQUE

EU/1/08/452/001

23.12.2009

22.12.2009

Stelara

| Janssen-Cilag International NV |
| --- |
| Turnhoutseweg 30 |
| 2340 Beerse |
| BELGIË |

Janssen-Cilag International NV

Turnhoutseweg 30

2340 Beerse

BELGIË

EU/1/08/494/001-002

24.12.2009

22.12.2009

Tasigna

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex |
| RH12 5AB |
| UNITED KINGDOM |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex

RH12 5AB

UNITED KINGDOM

EU/1/07/422/001-004

24.12.2009

22.12.2009

Replagal

| Shire Human Genetic Therapies AB |
| --- |
| Svärdvägen 11D |
| SE-182 33 Danderyd |
| SVERIGE |

Shire Human Genetic Therapies AB

Svärdvägen 11D

SE-182 33 Danderyd

SVERIGE

EU/1/01/189/001-006

28.12.2009

22.12.2009

Evra

| Janssen-Cilag International NV |
| --- |
| Turnhoutseweg 30 |
| 2340 Beerse |
| BELGIË |

Janssen-Cilag International NV

Turnhoutseweg 30

2340 Beerse

BELGIË

EU/1/02/223/001-003

24.12.2009

22.12.2009

Crixivan

| Merck Sharp & Dohme Ltd. |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire |
| EN11 9BU |
| UNITED KINGDOM |

Merck Sharp & Dohme Ltd.

Hertford Road

Hoddesdon

Hertfordshire

EN11 9BU

UNITED KINGDOM

EU/1/96/024/001-005

EU/1/96/024/008

EU/1/96/024/010

24.12.2009

22.12.2009

Onsior

| Novartis Animal Health UK Ltd. |
| --- |
| Frimley Business Park |
| Frimley/Camberley |
| Surrey |
| GU16 7SR |
| UNITED KINGDOM |

Novartis Animal Health UK Ltd.

Frimley Business Park

Frimley/Camberley

Surrey

GU16 7SR

UNITED KINGDOM

EU/2/08/089/001-021

24.12.2009

22.12.2009

RELISTOR

| Wyeth Europa Limited |
| --- |
| Huntercombe Lane South |
| Taplow |
| Maidenhead |
| Berkshire |
| SL6 0PH |
| UNITED KINGDOM |

Wyeth Europa Limited

Huntercombe Lane South

Taplow

Maidenhead

Berkshire

SL6 0PH

UNITED KINGDOM

EU/1/08/463/001-003

24.12.2009

23.12.2009

Tractocile

| Ferring Pharmaceuticals A/S |
| --- |
| Kay Fiskers Plads 11 |
| 2300 Copenhagen S |
| DANMARK |

Ferring Pharmaceuticals A/S

Kay Fiskers Plads 11

2300 Copenhagen S

DANMARK

EU/1/99/124/001-002

28.12.2009

23.12.2009

Biograstim

| CT Arzneimittel GmbH |
| --- |
| Lengeder Straße 42a |
| 13407 Berlin |
| DEUTSCHLAND |

CT Arzneimittel GmbH

Lengeder Straße 42a

13407 Berlin

DEUTSCHLAND

EU/1/08/450/001-010

29.12.2009

23.12.2009

Retacrit

| HOSPIRA Enterprises B.V. |
| --- |
| Taurusavenue 19-21b |
| 2132 LS Hoofddorp |
| NEDERLAND |

HOSPIRA Enterprises B.V.

Taurusavenue 19-21b

2132 LS Hoofddorp

NEDERLAND

EU/1/07/431/001-025

31.12.2009

23.12.2009

TORISEL

| Wyeth Europa Ltd |
| --- |
| Huntercombe Lane South |
| Taplow |
| Maidenhead |
| Berkshire |
| SL6 0PH |
| UNITED KINGDOM |

Wyeth Europa Ltd

Huntercombe Lane South

Taplow

Maidenhead

Berkshire

SL6 0PH

UNITED KINGDOM

EU/1/07/424/001

4.1.2010

23.12.2009

IVEMEND

| Merck Sharp & Dohme Limited |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire |
| EN11 9BU |
| UNITED KINGDOM |

Merck Sharp & Dohme Limited

Hertford Road

Hoddesdon

Hertfordshire

EN11 9BU

UNITED KINGDOM

EU/1/07/437/001-002

4.1.2010

23.12.2009

Alisade

| Glaxo Group Ltd, Greenford |
| --- |
| Middlesex |
| UB6 ONN |
| UNITED KINGDOM |

Glaxo Group Ltd, Greenford

Middlesex

UB6 ONN

UNITED KINGDOM

EU/1/08/474/001-003

4.1.2010

23.12.2009

Focetria

| Novartis Vaccines and Diagnostics S.r.l. |
| --- |
| Via Fiorentina 1 |
| Siena SI |
| ITALIA |

Novartis Vaccines and Diagnostics S.r.l.

Via Fiorentina 1

Siena SI

ITALIA

EU/1/07/385/001-002

EU/1/07/385/004

28.12.2009

—   Modification of a marketing authorization (Article 38 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 14.12.2009 | Aivlosin | ECO Animal Health Ltd. |
| 78 Coombe Road |
| New Malden |
| Surrey |
| KT3 4QS |
| UNITED KINGDOM |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

14.12.2009

Aivlosin

ECO Animal Health Ltd.

78 Coombe Road

New Malden

Surrey

KT3 4QS

UNITED KINGDOM

EU/2/04/044/011-012-013

16.12.2009

18.12.2009

Equioxx

| MERIAL |
| --- |
| 29 avenue Tony Garnier |
| 69007 Lyon |
| FRANCE |

MERIAL

29 avenue Tony Garnier

69007 Lyon

FRANCE

EU/2/08/083/002-003

22.12.2009

21.12.2009

Flexicam

| Dechra Veterinary Products A/S |
| --- |
| Mekuvej 9 |
| 7171 Uldum |
| DANMARK |

Dechra Veterinary Products A/S

Mekuvej 9

7171 Uldum

DANMARK

| Omnipharm Ltd. |
| --- |
| The Spire |
| Egypt Road |
| Nottingham |
| NG7 7GD |
| UNITED KINGDOM |

Omnipharm Ltd.

The Spire

Egypt Road

Nottingham

NG7 7GD

UNITED KINGDOM

EU/2/06/058/001-004

23.12.2009

Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

| The European Medicines Agency |
| --- |
| 7 Westferry Circus |
| Canary Wharf |
| London |
| E14 4HB |
| UNITED KINGDOM |

The European Medicines Agency

7 Westferry Circus

Canary Wharf

London

E14 4HB

UNITED KINGDOM

---

(1)  OJ L 136, 30.4.2004, p. 1.

---

| 29.1.2010 | EN | Official Journal of the European Union | C 22/28 |
| --- | --- | --- | --- |

29.1.2010

EN

Official Journal of the European Union

C 22/28

---

Summary of Community decisions on marketing authorisations in respect of medicinal products from 1 December 2009 to 31 December 2009

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council
   (1)
  or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council
   (2)
  )

2010/C 22/05

—   Issuing, maintenance or modification of a national marketing authorisation

| Date of the decision | Name(s) of the medicinal product | Holder(s) of the marketing authorisation | Member State concerned | Date of notification |
| --- | --- | --- | --- | --- |
| 16.12.2009 | REVLIMID | Celgene Europe Limited |
| Riverside House |
| Riverside Walk |
| Windsor |
| Berkshire |
| SL4 1NA |
| UNITED KINGDOM |

Date of the decision

Name(s) of the medicinal product

Holder(s) of the marketing authorisation

Member State concerned

Date of notification

16.12.2009

REVLIMID

Celgene Europe Limited

Riverside House

Riverside Walk

Windsor

Berkshire

SL4 1NA

UNITED KINGDOM

This Decision is addressed to the Member States

17.12.2009

10.12.2009

Effentora

| Cephalon Europe |
| --- |
| 5 rue Charles Martigny |
| 94700 Maisons-Alfort |
| FRANCE |

Cephalon Europe

5 rue Charles Martigny

94700 Maisons-Alfort

FRANCE

This Decision is addressed to the Member States

11.12.2009

21.12.2009

Revatio

| Pfizer Limited Sandwich |
| --- |
| Kent |
| CT13 9NJ |
| UNITED KINGDOM |

Pfizer Limited Sandwich

Kent

CT13 9NJ

UNITED KINGDOM

This Decision is addressed to the Member States

22.12.2009

---

(1)  OJ L 311, 28.11.2001, p. 67.

(2)  OJ L 311, 28.11.2001, p. 1.

---

Court of Auditors

| 29.1.2010 | EN | Official Journal of the European Union | C 22/29 |
| --- | --- | --- | --- |

29.1.2010

EN

Official Journal of the European Union

C 22/29

---

Special Report No 17/2009 ‘concerning vocational training actions for women co-financed by the European Social Fund’

2010/C 22/06

The European Court of Auditors hereby informs you that Special Report No 17/2009 ‘concerning vocational training actions for women co-financed by the European Social Fund’ has just been published.

The report can be accessed for consultation or downloading on the European Court of Auditors' website: http://www.eca.europa.eu

A hard copy and a CD-ROM version of the report may be obtained free of charge on request to the Court of Auditors:

| European Court of Auditors |
| --- |
| Communication and Reports Unit |
| 12, rue Alcide De Gasperi |
| 1615 Luxembourg |
| LUXEMBOURG |
| Tel. +352 4398-1 |
| E-mail: euraud@eca.europa.eu |

European Court of Auditors

Communication and Reports Unit

12, rue Alcide De Gasperi

1615 Luxembourg

LUXEMBOURG

Tel. +352 4398-1

E-mail: euraud@eca.europa.eu

or by filling in an electronic order form on EU-Bookshop.

---

NOTICES FROM MEMBER STATES

| 29.1.2010 | EN | Official Journal of the European Union | C 22/30 |
| --- | --- | --- | --- |

29.1.2010

EN

Official Journal of the European Union

C 22/30

---

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 800/2008 declaring certain categories of aid compatible with the common market in application of Articles 87 and 88 of the Treaty (General Block Exemption Regulation)

(Text with EEA relevance)

2010/C 22/07

| Reference number of State Aid | X 636/09 |
| --- | --- |
| Member State | Spain |
| Member State reference number | — |
| Name of the Region (NUTS) | Castilla-La Mancha
  Article 87(3)(a) |
| Granting authority | Consejería de Educación y Ciencia de la Junta de Comunidades de Castilla-La Mancha |
| Río Alberche, s/n |
| 45071 Toledo |
| ESPAÑA |
| http://www.educa.jccm.es |

Reference number of State Aid

X 636/09

Member State

Spain

Member State reference number

—

Name of the Region (NUTS)

Castilla-La Mancha

Article 87(3)(a)

Granting authority

Consejería de Educación y Ciencia de la Junta de Comunidades de Castilla-La Mancha

Río Alberche, s/n

45071 Toledo

ESPAÑA

http://www.educa.jccm.es

Title of the aid measure

Subvenciones complementarias de ayudas cdti en i+d de interés para Castilla-La Mancha

National legal basis (Reference to the relevant national official publication)

Ley 38/2003, de 17 de noviembre, general de subvenciones (B.O.E. No 276 de 18.11.2003)

Type of measure

Scheme

Amendment of an existing aid measure

—

Duration

7.3.2009-31.12.2012

Economic sector(s) concerned

All economic sectors eligible to receive aid

Type of beneficiary

SME

large enterprise

Annual overall amount of the budget planned under the scheme

EUR 3,00 million

For guarantees

—

Aid Instrument (Article 5)

Grant

Reference to the Commission Decision

—

If co-financed by Community funds

—

Objectives

Maximum aid intensity in % or maximum aid amount in national currency

SME-bonuses in %

Industrial research (Article 31(2)(b))

10 %

—

Experimental development (Article 31(2)(c))

10 %

—

Web link to the full text of the aid measure:

http://docm.jccm.es/portaldocm/descargarArchivo.do?ruta=2009/03/06/pdf/2009_3138.pdf&tipo=rutaDocm

| Reference number of State Aid | X 638/09 |
| --- | --- |
| Member State | Czech Republic |
| Member State reference number | 25580/09/08100 |
| Name of the Region (NUTS) | Strední Cechy, Jihozápad, Severozápad, Severovýchod, Jihovýchod, Strední Morava, Moravskoslezko
  Article 87(3)(a) |
| Granting authority | Ministerstvo průmyslu a obchodu |
| Na Františku 32 |
| 110 15 Praha 1 |
| ČESKÁ REPUBLIKA |
| http://www.mpo.cz |

Reference number of State Aid

X 638/09

Member State

Czech Republic

Member State reference number

25580/09/08100

Name of the Region (NUTS)

Strední Cechy, Jihozápad, Severozápad, Severovýchod, Jihovýchod, Strední Morava, Moravskoslezko

Article 87(3)(a)

Granting authority

Ministerstvo průmyslu a obchodu

Na Františku 32

110 15 Praha 1

ČESKÁ REPUBLIKA

http://www.mpo.cz

Title of the aid measure

Nemovitosti–2. výzva

National legal basis (Reference to the relevant national official publication)

Zákon č. 47/2002 Sb, o podpoře malého a středního podnikání;

Zákon č. 218/2000 Sb., o rozpočtových pravidlech a o změně některých souvisejících zákonů;

Zákon č. 513/1991 Sb., obchodní zákoník.

Type of measure

Scheme

Amendment of an existing aid measure

—

Duration

1.7.2009-30.4.2012

Economic sector(s) concerned

All economic sectors eligible to receive aid

Type of beneficiary

SME

large enterprise

Annual overall amount of the budget planned under the scheme

CZK 4 000,00 million

For guarantees

—

Aid Instrument (Article 5)

Grant

Reference to the Commission Decision

—

If co-financed by Community funds

Strukturální fondy-ERDF – 85 % – 600,00 CZK (v milionech)

Objectives

Maximum aid intensity in % or maximum aid amount in national currency

SME-bonuses in %

Regional investment and employment aid (Article 13) Scheme

40 %

20 %

Web link to the full text of the aid measure:

http://www.mpo.cz/dokument38212.html

| Reference number of State Aid | X 639/09 |
| --- | --- |
| Member State | Belgium |
| Member State reference number | BE |
| Name of the Region (NUTS) | région Wallonne
  Mixed |
| Granting authority | Service public de Wallonie DGO6 «Économie, emploi et recherche» |
| Place de la Wallonie, 1 bât 2 |
| 5100 Jambes |
| BELGIQUE |
| http://economie.wallonie.be |

Reference number of State Aid

X 639/09

Member State

Belgium

Member State reference number

BE

Name of the Region (NUTS)

région Wallonne

Mixed

Granting authority

Service public de Wallonie DGO6 «Économie, emploi et recherche»

Place de la Wallonie, 1 bât 2

5100 Jambes

BELGIQUE

http://economie.wallonie.be

Title of the aid measure

Incitants en faveur des entreprises destinés à favoriser la protection de l’environnement et l’utilisation durable de l’énergie

National legal basis (Reference to the relevant national official publication)

Décret du 11 mars 2004 relatif aux incitants destinés à favoriser la protection de l’environnement et l’utilisation durable de l’énergie

(M.B. du 8.4.2004, p. 19628)

Arrêté du gouvernement wallon du 2 décembre 2004 portant exécution du décret du 11 mars 2004 relatif aux incitants destinés à favoriser la protection de l’environnement et l’utilisation durable de l’énergie modifié par l’arrêté du Gouvernement du 14 mai 2009

(M.B. du 17.6.2009, p. 42421)

Type of measure

Scheme

Amendment of an existing aid measure

Modification N 15/03

Duration

27.6.2009-31.12.2013

Economic sector(s) concerned

All economic sectors eligible to receive aid

Type of beneficiary

SME

large enterprise

Annual overall amount of the budget planned under the scheme

EUR 15,00 million

For guarantees

—

Aid Instrument (Article 5)

Fiscal measure, Grant

Reference to the Commission Decision

—

If co-financed by Community funds

—

Objectives

Maximum aid intensity in % or maximum aid amount in national currency

SME-bonuses in %

Investment aid enabling undertakings to go beyond Community standards for environmental protection or increase the level of environmental protection in the absence of Community standards (Article 18)

30 %

10 %

Aid for early adaptation to future Community standards for SMEs (Article 20)

15 %

—

Environmental investment aid for energy saving measures (Article 21)

20 %

20 %

Environmental investment aid for high efficiency cogeneration (Article 22)

30 %

20 %

Environmental investment aid for the promotion of energy from renewable energy sources (Article 23)

30 %

20 %

Web link to the full text of the aid measure:

http://wallex.wallonie.be/index.php?doc=3770&rev=3099-8724

http://wallex.wallonie.be/index.php?doc=3774&rev=3103-3436

| Reference number of State Aid | X 640/09 |
| --- | --- |
| Member State | Ireland |
| Member State reference number | — |
| Name of the Region (NUTS) | — |
| Granting authority | Sustainable Energy Ireland |
| Wilton Park House |
| Wilton Place |
| Dublin 2 |
| IRELAND |
| http://www.sei.ie |

Reference number of State Aid

X 640/09

Member State

Ireland

Member State reference number

—

Name of the Region (NUTS)

—

Granting authority

Sustainable Energy Ireland

Wilton Park House

Wilton Place

Dublin 2

IRELAND

http://www.sei.ie

Title of the aid measure

Supports for Exemplar Energy Efficiency Projects (SEEEP)

National legal basis (Reference to the relevant national official publication)

Support for Exemplar Energy Efficiency Projects programme manual

Type of measure

Scheme

Amendment of an existing aid measure

—

Duration

1.7.2009-31.12.2009

Economic sector(s) concerned

All economic sectors eligible to receive aid

Type of beneficiary

SME

large enterprise

Annual overall amount of the budget planned under the scheme

EUR 1,50 million

For guarantees

—

Aid Instrument (Article 5)

Grant

Reference to the Commission Decision

—

If co-financed by Community funds

—

Objectives

Maximum aid intensity in % or maximum aid amount in national currency

SME-bonuses in %

Investment aid enabling undertakings to go beyond Community standards for environmental protection or increase the level of environmental protection in the absence of Community standards (Article 18)

35 %

—

Web link to the full text of the aid measure:

http://www.sei.ie/your_business/public_sector/grants

| Reference number of State Aid | X 642/09 |
| --- | --- |
| Member State | Netherlands |
| Member State reference number | VENW/DGMO-2009/6185 |
| Name of the Region (NUTS) | Nederland
  Mixed |
| Granting authority | Minister van Verkeer en Waterstaat |
| Postbus 20901 |
| 2500 EX Den Haag |
| NEDERLAND |
| http://www.verkeerenwaterstaat.nl/ |

Reference number of State Aid

X 642/09

Member State

Netherlands

Member State reference number

VENW/DGMO-2009/6185

Name of the Region (NUTS)

Nederland

Mixed

Granting authority

Minister van Verkeer en Waterstaat

Postbus 20901

2500 EX Den Haag

NEDERLAND

http://www.verkeerenwaterstaat.nl/

Title of the aid measure

Regeling van de Minister van Verkeer en Waterstaat houdende bepalingen met betrekking tot de verstrekking van subsidies voor duurzame mobiliteit, logistiek en duurzaam waterbeheer (Kaderregeling subsidies duurzaamheid verkeer en waterstaat)

National legal basis (Reference to the relevant national official publication)

Regeling van de Minister van Verkeer en Waterstaat houdende bepalingen met betrekking tot de verstrekking van subsidies voor duurzame mobiliteit, logistiek en duurzaam waterbeheer (Kaderregeling subsidies duurzaamheid verkeer en waterstaat)

De Kaderregeling subsidie duurzaamheid verkeer en waterstaat is gebaseerd op de Kaderwet subsidies Verkeer en Waterstaat

Type of measure

Scheme

Amendment of an existing aid measure

—

Duration

15.7.2009-15.7.2015

Economic sector(s) concerned

All economic sectors eligible to receive aid

Type of beneficiary

SME

large enterprise

Annual overall amount of the budget planned under the scheme

EUR 125,00 million

For guarantees

—

Aid Instrument (Article 5)

Other, Grant, Repayable advances — Aangezien specificatie/toelichting in Deel II niet mogelijk is, is deze informatie hier opgenomen (geen ander instrument):

Steun voor fundamenteel onderzoek: ook in de vorm van terugbetaalbaar voorschot mogelijk

Steun voor industrieel onderzoek: naast verhoging voor kmo, ook verhoging van 15 % tot maximaal 80 % mogelijk (art. 31, lid 4 sub b GBER)

Steun voor experimentele ontwikkeling: naast verhoging voor kmo, ook verhoging van 15 % mogelijk (art. 31, lid 4 sub b GBER)

Steun voor technische haalbaarheidsstudies: 65 % (indust.) 40 % (exp.), met kmo-verhoging van 10 %

Overige kmo-verhogingen: max. 20 % (KO) en 10 % (MO)

Steun voor het uitlenen van hooggekwalificeerd personeel: 50 % gedurende max. drie jaar per onderneming of entiteit en per ingeleende werknemer

Reference to the Commission Decision

—

If co-financed by Community funds

—

Objectives

Maximum aid intensity in % or maximum aid amount in national currency

SME-bonuses in %

Aid for environmental studies (Article 24)

50 %

20 %

Aid for consultancy in favour of SMEs (Article 26)

50 %

—

Aid for SME participation in fairs (Article 27)

50 %

—

Fundamental research (Article 31(2)(a))

100 %

—

Industrial research (Article 31(2)(b))

50 %

20 %

Experimental development (Article 31(2)(c))

25 %

20 %

Aid for technical feasibility studies (Article 32)

75 %

—

Aid for innovation advisory services and for innovation support services (Article 36)

EUR 200 000,00

—

Aid for the loan of highly qualified personnel (Article 37)

—

—

General training (Article 38(2))

60 %

20 %

Web link to the full text of the aid measure:

http://zoek.officielebekendmakingen.nl/stcrt-2009-10400.html

---

| 29.1.2010 | EN | Official Journal of the European Union | C 22/36 |
| --- | --- | --- | --- |

29.1.2010

EN

Official Journal of the European Union

C 22/36

---

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 800/2008 declaring certain categories of aid compatible with the common market in application of Articles 87 and 88 of the Treaty (General Block Exemption Regulation)

(Text with EEA relevance)

2010/C 22/08

| Reference number of State Aid | X 661/09 |
| --- | --- |
| Member State | Germany |
| Member State reference number | — |
| Name of the Region (NUTS) | Deutschland
  Article 87(3)(a) |
| Granting authority | Bundesamt für Wirtschaft und Ausfuhrkontrolle |
| Postfach 5160 |
| 65726 Eschborn |
| DEUTSCHLAND |
| http://www.bafa.de |

Reference number of State Aid

X 661/09

Member State

Germany

Member State reference number

—

Name of the Region (NUTS)

Deutschland

Article 87(3)(a)

Granting authority

Bundesamt für Wirtschaft und Ausfuhrkontrolle

Postfach 5160

65726 Eschborn

DEUTSCHLAND

http://www.bafa.de

Title of the aid measure

Richtlinie zur Förderung von Maßnahmen an gewerblichen Kälteanlagen vom 1.9.2008, zuletzt geändert am 1.1.2009

National legal basis (Reference to the relevant national official publication)

Bundesanzeiger, Juni 2008, S. 2344

http://www.bundesanzeiger.de/old/banz/banzinha/BAnz_60_096.htm

Type of measure

Scheme

Amendment of an existing aid measure

—

Duration

1.9.2008-31.12.2012

Economic sector(s) concerned

All economic sectors eligible to receive aid

Type of beneficiary

SME

large enterprise

Annual overall amount of the budget planned under the scheme

EUR 40,00 million

For guarantees

—

Aid Instrument (Article 5)

Grant

Reference to the Commission Decision

—

If co-financed by Community funds

—

Objectives

Maximum aid intensity in % or maximum aid amount in national currency

SME-bonuses in %

Environmental investment aid for energy saving measures (Article 21)

58 %

—

Web link to the full text of the aid measure:

http://www.bmu.de/files/pdfs/allgemein/application/pdf/foerderrichtlinie_kaelte.pdf

http://www.kaelte-effizienz.de

| Reference number of State Aid | X 662/09 |
| --- | --- |
| Member State | Germany |
| Member State reference number | — |
| Name of the Region (NUTS) | Deutschland
  Article 87(3)(a) |
| Granting authority | Bundesamt für Wirtschaft und Ausfuhrkontrolle |
| Postfach 5160 |
| 65726 Eschborn |
| DEUTSCHLAND |
| http://www.bafa.de |

Reference number of State Aid

X 662/09

Member State

Germany

Member State reference number

—

Name of the Region (NUTS)

Deutschland

Article 87(3)(a)

Granting authority

Bundesamt für Wirtschaft und Ausfuhrkontrolle

Postfach 5160

65726 Eschborn

DEUTSCHLAND

http://www.bafa.de

Title of the aid measure

Richtlinie zur Förderung von Mini-KWK-Anlagen vom 1.9.2008, zuletzt geändert am 1.1.2009

National legal basis (Reference to the relevant national official publication)

Bundesanzeiger, Juni 2008, S. 2342

http://www.bundesanzeiger.de/old/banz/banzinha/BAnz_60_096.htm

Type of measure

Scheme

Amendment of an existing aid measure

—

Duration

1.9.2008-31.12.2012

Economic sector(s) concerned

All economic sectors eligible to receive aid

Type of beneficiary

SME

large enterprise

Annual overall amount of the budget planned under the scheme

EUR 20,00 million

For guarantees

—

Aid Instrument (Article 5)

Grant

Reference to the Commission Decision

—

If co-financed by Community funds

—

Objectives

Maximum aid intensity in % or maximum aid amount in national currency

SME-bonuses in %

Environmental investment aid for high efficiency cogeneration (Article 22)

28 %

—

Web link to the full text of the aid measure:

http://www.mini-kwk.de

http://www.bmu.de/files/pdfs/allgemein/application/pdf/foerderrichtlinie_minikwk.pdf

| Reference number of State Aid | X 663/09 |
| --- | --- |
| Member State | Estonia |
| Member State reference number | — |
| Name of the Region (NUTS) | Estonia
  Article 87(3)(a) |
| Granting authority | Ettevõtluse Arendamise Sihtasutus |
| Lasnamäe 2 |
| 11412 Tallinn |
| EESTI/ESTONIA |
| http://www.eas.ee |

Reference number of State Aid

X 663/09

Member State

Estonia

Member State reference number

—

Name of the Region (NUTS)

Estonia

Article 87(3)(a)

Granting authority

Ettevõtluse Arendamise Sihtasutus

Lasnamäe 2

11412 Tallinn

EESTI/ESTONIA

http://www.eas.ee

Title of the aid measure

Kompetentsikeskuste arendamine

National legal basis (Reference to the relevant national official publication)

Regionaalministri 3. juuli 2009. aasta määrus nr 10 „Meetme „Kompetentsikeskuste arendamine“ tingimused“ (RTL, 13.7.2009, 56, 820).

Type of measure

Scheme

Amendment of an existing aid measure

—

Duration

16.7.2009-31.12.2013

Economic sector(s) concerned

All economic sectors eligible to receive aid

Type of beneficiary

SME

large enterprise

Annual overall amount of the budget planned under the scheme

EEK 60,00 million

For guarantees

—

Aid Instrument (Article 5)

Grant

Reference to the Commission Decision

—

If co-financed by Community funds

Euroopa Regionaalarengu Fond – 60,00 EEK (miljonites)

Objectives

Maximum aid intensity in % or maximum aid amount in national currency

SME-bonuses in %

Regional investment and employment aid (Article 13) Scheme

50 %

20 %

Industrial research (Article 31(2)(b))

50 %

—

Experimental development (Article 31(2)(c))

25 %

—

Web link to the full text of the aid measure:

http://www.riigiteataja.ee/ert/act.jsp?id=13201666

| Reference number of State Aid | X 665/09 |
| --- | --- |
| Member State | Italy |
| Member State reference number | itd1 |
| Name of the Region (NUTS) | Bolzano-Bozen
  Article 87(3)(c) |
| Granting authority | Provincia autonoma di Bolzano |
| Ripartizione 39 |
| Affari comunitari — Ufficio FSE |
| Via Conciapelli 69 |
| 39100 Bolzano BZ |
| ITALIA |
| http://www.provincia.bz.it/fse |

Reference number of State Aid

X 665/09

Member State

Italy

Member State reference number

itd1

Name of the Region (NUTS)

Bolzano-Bozen

Article 87(3)(c)

Granting authority

Provincia autonoma di Bolzano

Ripartizione 39

Affari comunitari — Ufficio FSE

Via Conciapelli 69

39100 Bolzano BZ

ITALIA

http://www.provincia.bz.it/fse

Title of the aid measure

Regime quadro d’aiuti della Provincia autonoma di Bolzano, ai sensi degli articoli 38 e 39 del regolamento (CE) n. 800/2008 del 6 agosto 2008: aiuti destinati alle imprese operanti nel territorio della Provincia autonoma di Bolzano appartenenti ai settori esposti alla concorrenza internazionale e che sono rivolti alla formazione, alla riqualificazione ed aggiornamento dei loro addetti.

National legal basis (Reference to the relevant national official publication)

Delibera della Giunta provinciale n. 1653 del 22.6.2009 pubblicata nel Bollettino Ufficiale della Regione autonoma Trentino — Alto Adige n. 29 del 14.7.2009.

Legge provinciale 29 luglio 1986, n. 20 — Progetti di formazione professionale da realizzare con i contributi del fondo sociale europeo

Type of measure

Scheme

Amendment of an existing aid measure

—

Duration

22.6.2009-30.6.2014

Economic sector(s) concerned

All economic sectors eligible to receive aid

Type of beneficiary

SME

large enterprise

Annual overall amount of the budget planned under the scheme

EUR 10,00 million

For guarantees

—

Aid Instrument (Article 5)

Grant

Reference to the Commission Decision

—

If co-financed by Community funds

Programma operativo regionale FSE 2007-2013 della Provincia autonoma di Bolzano (2007 IT 052 PO 009) — 22,70 milioni di EUR

Objectives

Maximum aid intensity in % or maximum aid amount in national currency

SME-bonuses in %

Specific training (Article 38(1))

25 %

20 %

General training (Article 38(2))

60 %

20 %

Web link to the full text of the aid measure:

http://www.provincia.bz.it/europa/fse/temi/559.asp

http://www.provincia.bz.it/europa/fse/download/Regime_quadro_aiuti_formazione_it_de.pdf

http://www.provinz.bz.it/europa/esf/themen/559.asp

| Reference number of State Aid | X 666/09 |
| --- | --- |
| Member State | Latvia |
| Member State reference number | — |
| Name of the Region (NUTS) | Latvia
  Article 87(3)(a) |
| Granting authority | LR Vides ministrija |
| Peldu iela 25 |
| Rīga, LV-1494 |
| LATVIJA |
| http://www.vidm.gov.lv |

Reference number of State Aid

X 666/09

Member State

Latvia

Member State reference number

—

Name of the Region (NUTS)

Latvia

Article 87(3)(a)

Granting authority

LR Vides ministrija

Peldu iela 25

Rīga, LV-1494

LATVIJA

http://www.vidm.gov.lv

Title of the aid measure

atklātais konkurss “Vides tehnoloģijas un ekoinovācija”

National legal basis (Reference to the relevant national official publication)

Ministru kabineta 2009. gada 13. janvāra noteikumi Nr. 43 “Eiropas Ekonomikas zonas finanšu instrumenta līdzfinansētās programmas “Vides politikas integrācijas programma Latvijā” apakšprojektu iesniegumu atklāta konkursa “Vides tehnoloģijas un ekoinovācija” nolikums” (publicēts: Latvijas Vēstnesis, 3.2.2009., Nr. 18)

Type of measure

Scheme

Amendment of an existing aid measure

—

Duration

6.2.2009-31.12.2010

Economic sector(s) concerned

All economic sectors eligible to receive aid

Type of beneficiary

SME

large enterprise

Annual overall amount of the budget planned under the scheme

LVL 1,80 million

For guarantees

—

Aid Instrument (Article 5)

Grant

Reference to the Commission Decision

—

If co-financed by Community funds

—

Objectives

Maximum aid intensity in % or maximum aid amount in national currency

SME-bonuses in %

Regional investment and employment aid (Article 13) Scheme

50 %

20 %

Experimental development (Article 31(2)(c))

25 %

20 %

Web link to the full text of the aid measure:

http://www.likumi.lv/doc.php?id=187239

---

| 29.1.2010 | EN | Official Journal of the European Union | C 22/41 |
| --- | --- | --- | --- |

29.1.2010

EN

Official Journal of the European Union

C 22/41

---

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 800/2008 declaring certain categories of aid compatible with the common market in application of Articles 87 and 88 of the Treaty (General Block Exemption Regulation)

(Text with EEA relevance)

2010/C 22/09

| Reference number of State Aid | X 660/09 |
| --- | --- |
| Member State | Germany |
| Member State reference number | — |
| Name of the Region (NUTS) | Hamburg
  Non-assisted areas |
| Granting authority | Behörde für Stadtentwicklung und Umwelt |
| Stadthausbrücke 8 |
| 20355 Hamburg |
| DEUTSCHLAND |
| http://www.hamburg.de/umwelt |

Reference number of State Aid

X 660/09

Member State

Germany

Member State reference number

—

Name of the Region (NUTS)

Hamburg

Non-assisted areas

Granting authority

Behörde für Stadtentwicklung und Umwelt

Stadthausbrücke 8

20355 Hamburg

DEUTSCHLAND

http://www.hamburg.de/umwelt

Title of the aid measure

Vorerwärmung von Kesselspeisewasser durch Wärmerückgewinnung

National legal basis (Reference to the relevant national official publication)

§ 44 LHO (Hamburg)

Type of measure

Ad hoc aid

HOBUM Oleochemicals GmbH

Amendment of an existing aid measure

—

Date of granting

1.7.2009

Economic sector(s) concerned

Manufacture of chemicals and chemical products

Type of beneficiary

SME

Overall amount of the ad hoc aid awarded to the undertaking

EUR 0,01 million

For guarantees

—

Aid Instrument (Article 5)

Grant

Reference to the Commission Decision

—

If co-financed by Community funds

—

Objectives

Maximum aid intensity in % or maximum aid amount in national currency

SME-bonuses in %

Environmental investment aid for energy saving measures (Article 21)

30 %

—

Web link to the full text of the aid measure:

http://www.hamburg.de/start-teilnehmer/1281752/eg-gruppenfreistellungsverordnung.html

| Reference number of State Aid | X 669/09 |
| --- | --- |
| Member State | Poland |
| Member State reference number | PL |
| Name of the Region (NUTS) | Poland
  Article 87(3)(a) |
| Granting authority | Narodowe Centrum Badań i Rozwoju |
| ul. ks. Skorupki 4 |
| 00-546 Warszawa |
| POLSKA/POLAND |
| http://www.ncbir.gov.pl |

Reference number of State Aid

X 669/09

Member State

Poland

Member State reference number

PL

Name of the Region (NUTS)

Poland

Article 87(3)(a)

Granting authority

Narodowe Centrum Badań i Rozwoju

ul. ks. Skorupki 4

00-546 Warszawa

POLSKA/POLAND

http://www.ncbir.gov.pl

Title of the aid measure

Udzielanie pomocy za pośrednictwem Narodowego Centrum Badań i Rozwoju

National legal basis (Reference to the relevant national official publication)

Artykuł 4 ust. 5 ustawy z dnia 15 czerwca 2007 r. o Narodowym Centrum Badań i Rozwoju (Dz. U. Nr 115, poz. 789), rozporządzenie Ministra Nauki i Szkolnictwa Wyższego z dnia 20 maja 2009 r. w sprawie warunków i trybu udzielania pomocy publicznej za pośrednictwem Narodowego Centrum Badań i Rozwoju (Dz. U. Nr 89, poz. 732)

Type of measure

Scheme

Amendment of an existing aid measure

—

Duration

18.6.2009-31.12.2013

Economic sector(s) concerned

All economic sectors eligible to receive aid

Type of beneficiary

SME

large enterprise

Annual overall amount of the budget planned under the scheme

PLN 80,00 million

For guarantees

—

Aid Instrument (Article 5)

Grant

Reference to the Commission Decision

—

If co-financed by Community funds

—

Objectives

Maximum aid intensity in % or maximum aid amount in national currency

SME-bonuses in %

Fundamental research (Article 31(2)(a))

100 %

—

Industrial research (Article 31(2)(b))

80 %

20 %

Experimental development (Article 31(2)(c))

60 %

20 %

Aid for technical feasibility studies (Article 32)

75 %

—

Aid for industrial property rights costs for SMEs (Article 33)

100 %

—

Aid for innovation advisory services and for innovation support services (Article 36)

PLN 880 900

—

Aid for the loan of highly qualified personnel (Article 37)

PLN 200 000

—

Web link to the full text of the aid measure:

http://www.ncbir.pl/www/images/doc/spb/Konkurs/Rozporzadzenie%20o%20pomocy%20pulicznej.pdf

| Reference number of State Aid | X 670/09 |
| --- | --- |
| Member State | Austria |
| Member State reference number | — |
| Name of the Region (NUTS) | Oberoesterreich
  Mixed |
| Granting authority | Amt der oberösterreichischen Landesregierung |
| Amt der oö LR |
| Dirketion Verfassungsdienst |
| 4021 Linz |
| ÖSTERREICH |
| http://www.ooe.gv.at |

Reference number of State Aid

X 670/09

Member State

Austria

Member State reference number

—

Name of the Region (NUTS)

Oberoesterreich

Mixed

Granting authority

Amt der oberösterreichischen Landesregierung

Amt der oö LR

Dirketion Verfassungsdienst

4021 Linz

ÖSTERREICH

http://www.ooe.gv.at

Title of the aid measure

Förderungsrichtlinien des Landes Oberösterreich für gewässerökologische Maßnahmen für Wettbewerbsteilnehmer

National legal basis (Reference to the relevant national official publication)

Allgemeine Förderungsrichtlinien des Landes Oberösterreich

Type of measure

Scheme

Amendment of an existing aid measure

—

Duration

6.7.2009-31.10.2013

Economic sector(s) concerned

All economic sectors eligible to receive aid

Type of beneficiary

SME

large enterprise

Annual overall amount of the budget planned under the scheme

EUR 2,00 million

For guarantees

—

Aid Instrument (Article 5)

Grant

Reference to the Commission Decision

—

If co-financed by Community funds

—

Objectives

Maximum aid intensity in % or maximum aid amount in national currency

SME-bonuses in %

Investment aid enabling undertakings to go beyond Community standards for environmental protection or increase the level of environmental protection in the absence of Community standards (Article 18)

10 %

24 %

Web link to the full text of the aid measure:

http://www.land-oberoesterreich.gv.at/cps/rde/xchg/SID-595A8C2F-ACA92550/ooe/hs.xsl/86736_DEU_HTML.htm

| Reference number of State Aid | X 671/09 |
| --- | --- |
| Member State | United Kingdom |
| Member State reference number | — |
| Name of the Region (NUTS) | East Midlands, West Midlands
  Article 87(3)(c) |
| Granting authority | Birmingham City University |
| City North Campus |
| Birmingham |
| West Midlands |
| B42 2SU |
| UNITED KINGDOM |
| http://www.bcu.ac.uk |

Reference number of State Aid

X 671/09

Member State

United Kingdom

Member State reference number

—

Name of the Region (NUTS)

East Midlands, West Midlands

Article 87(3)(c)

Granting authority

Birmingham City University

City North Campus

Birmingham

West Midlands

B42 2SU

UNITED KINGDOM

http://www.bcu.ac.uk

Title of the aid measure

The HEFCE Economic Challenge Investment Fund (ECIF)

National legal basis (Reference to the relevant national official publication)

A higher education corporation by virtue of the Education Reform Act 1988

Type of measure

Scheme

Amendment of an existing aid measure

—

Duration

27.4.2009-30.9.2010

Economic sector(s) concerned

Manufacturing, water supply; sewerage, waste management and remediation activities, construction, wholesale and retail trade; repair of motor vehicles and motorcycles, real estate activities

Type of beneficiary

SME

large enterprise

Annual overall amount of the budget planned under the scheme

GBP 0,33 million

For guarantees

—

Aid Instrument (Article 5)

Other — Training Programme

Reference to the Commission Decision

—

If co-financed by Community funds

—

Objectives

Maximum aid intensity in % or maximum aid amount in national currency

SME-bonuses in %

General training (Article 38(2))

80 %

—

Web link to the full text of the aid measure:

http://www.bcu.ac.uk/docs/downloads/business/ECIF%20GBER%20Info%20for%20the%20BCU%20website%20-%203.08.09.doc

http://www.bcu.ac.uk/gber

| Reference number of State Aid | X 673/09 |
| --- | --- |
| Member State | United Kingdom |
| Member State reference number | — |
| Name of the Region (NUTS) | Northern Ireland
  Article 87(3)(c) |
| Granting authority | InterTradeIreland |
| Old Gasworks Business Park |
| Kilmorey Street |
| Newry |
| Co. Down |
| Northern Ireland |
| BT34 2DE |
| UNITED KINGDOM |
| http://www.intertradeireland.com |

Reference number of State Aid

X 673/09

Member State

United Kingdom

Member State reference number

—

Name of the Region (NUTS)

Northern Ireland

Article 87(3)(c)

Granting authority

InterTradeIreland

Old Gasworks Business Park

Kilmorey Street

Newry

Co. Down

Northern Ireland

BT34 2DE

UNITED KINGDOM

http://www.intertradeireland.com

Title of the aid measure

Fusion — Phase III

National legal basis (Reference to the relevant national official publication)

European Communities Act 1972

British Irish Agreement Act 1999 Section 2.3 Part 7 of Annex II of the Act empowers InterTradeIreland to invest, grant aid or lend for the purposes of its function

Type of measure

Scheme

Amendment of an existing aid measure

Modification XT 46a/04

Duration

8.6.2009-31.12.2013

Economic sector(s) concerned

All economic sectors eligible to receive aid

Type of beneficiary

SME

large enterprise

Annual overall amount of the budget planned under the scheme

GBP 2,50 million

For guarantees

—

Aid Instrument (Article 5)

Grant

Reference to the Commission Decision

—

If co-financed by Community funds

—

Objectives

Maximum aid intensity in % or maximum aid amount in national currency

SME-bonuses in %

General training (Article 38(2))

60 %

20 %

Web link to the full text of the aid measure:

http://www.statutelaw.gov.uk/legResults.aspx?ActiveTextDocId=1374459&source=OPSI

http://www.intertradeireland.com/index.cfm/area/information/page/State%20Aid

---

V Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

| 29.1.2010 | EN | Official Journal of the European Union | C 22/46 |
| --- | --- | --- | --- |

29.1.2010

EN

Official Journal of the European Union

C 22/46

---

Communication from the Minister for Economic Affairs of the Kingdom of the Netherlands pursuant to Article 3(2) of Directive 94/22/EC of the European Parliament and of the Council on the conditions for granting and using authorisations for the prospection, exploration and production of hydrocarbons

2010/C 22/10

The Minister for Economic Affairs hereby gives notice that an application has been received for authorisation to prospect for hydrocarbons in block segment L11c as indicated on the map appended as Annex 3 to the Mining Regulation (Mijnbouwregeling) (Government Gazette (Staatscourant) 2002, No 245).

With reference to the Directive mentioned in the introduction and Article 15 of the Mining Act (Mijnbouwwet) (Bulletin of Acts and Decrees (Staatsblad) 2002, No 542), the Minister for Economic Affairs hereby invites interested parties to submit a competing application for authorisation to prospect for hydrocarbons in block segment L11c of the Dutch continental shelf.

The Minister for Economic Affairs is the competent authority for the granting of authorisations. The criteria, conditions and requirements referred to in Articles 5(1), 5(2) and 6(2) of the above-mentioned Directive are set out in the Mining Act (Bulletin of Acts and Decrees 2002, No 542).

Block segment L11c is delimited by the parallel arcs between vertex pairs A-B and C-D, the meridian arc between vertices B and C and the great circle between vertex pairs D-E and E-A.

The coordinates of the vertices are as follows:

| A | 4° 33′ 3,100′′ E and 53° 30′ 0,000′′ |
| --- | --- |

A

4° 33′ 3,100′′ E and 53° 30′ 0,000′′

| B | 4° 40′ 0,000′′ E and 53° 30′ 0,000′′ |
| --- | --- |

B

4° 40′ 0,000′′ E and 53° 30′ 0,000′′

| C | 4° 40′ 0,000′′ E and 53° 20′ 0,000′′ |
| --- | --- |

C

4° 40′ 0,000′′ E and 53° 20′ 0,000′′

| D | 4° 34′ 0,000′′ E and 53° 20′ 0,000′′ |
| --- | --- |

D

4° 34′ 0,000′′ E and 53° 20′ 0,000′′

| E | 4° 29′ 2,000′′ E and 53° 24′ 57,000′′ |
| --- | --- |

E

4° 29′ 2,000′′ E and 53° 24′ 57,000′′

Applications may be submitted during the 13 weeks following the publication of this notice in the Official Journal of the European Union and should be sent to:

| De Minister van Economische Zaken |
| --- |
| ter attentie van drs. J.C. De Groot, directeur Energiemarkt |
| ALP A/562 |
| Postbus 20101 |
| 2500 EC Den Haag |
| NEDERLAND |

De Minister van Economische Zaken

ter attentie van drs. J.C. De Groot, directeur Energiemarkt

ALP A/562

Postbus 20101

2500 EC Den Haag

NEDERLAND

Applications received after the expiry of this period will not be considered.

A decision on the applications will be taken not later than 12 months after this period has expired.

Further information can be obtained by calling Mr P.C. de Regt on the following telephone number: +31 703797382.

---

OTHER ACTS

European Commission

| 29.1.2010 | EN | Official Journal of the European Union | C 22/48 |
| --- | --- | --- | --- |

29.1.2010

EN

Official Journal of the European Union

C 22/48

---

Publication of an amendment application pursuant to Article 6(2) of Council Regulation (EC) No 510/2006 on the protection of geographical indications and designations of origin for agricultural products and foodstuffs

2010/C 22/11

This publication confers the right to object to the amendment application pursuant to Article 7 of Council Regulation (EC) No 510/2006. Statements of objection must reach the Commission within six months of the date of this publication.

AMENDMENT APPLICATION

COUNCIL REGULATION (EC) No 510/2006

Amendment application pursuant to Article 9

‘CAPPERO DI PANTELLERIA’

EC No: IT-PGI-0317-0307-29.05.2007

PGI ( X ) PDO ( )

1.   Heading in the specification affected by the amendment:

| — |  | Name of product |
| --- | --- | --- |
| — | | Description of product |
| — |  | Geographical area |
| — |  | Proof of origin |
| — | | Method of production |
| — |  | Link |
| — |  | Labelling |
| — | | National requirements |
| — |  | Other (to be specified) |

—



Name of product

—

Image

Description of product

—



Geographical area

—



Proof of origin

—

Image

Method of production

—



Link

—



Labelling

—

Image

National requirements

—



Other (to be specified)

2.   Type of amendment(s):

| — |  | Amendment to Single Document or Summary Sheet |
| --- | --- | --- |
| — | | Amendment to Specification of registered PDO or PGI for which neither the Single Document nor the Summary has been published |
| — |  | Amendment to Specification that requires no amendment to the published Single Document (Article 9(3) of Regulation (EC) No 510/2006) |
| — |  | Temporary amendment to Specification resulting from imposition of obligatory sanitary or phytosanitary measures by public authorities (Article 9(4) of Regulation (EC) No 510/2006) |

—



Amendment to Single Document or Summary Sheet

—

Image

Amendment to Specification of registered PDO or PGI for which neither the Single Document nor the Summary has been published

—



Amendment to Specification that requires no amendment to the published Single Document (Article 9(3) of Regulation (EC) No 510/2006)

—



Temporary amendment to Specification resulting from imposition of obligatory sanitary or phytosanitary measures by public authorities (Article 9(4) of Regulation (EC) No 510/2006)

3.   Amendment(s):

3.1.   Description:

The possibility of using a maximum of 10 % of other varieties has been removed so as further to strengthen the link between the product and its area of origin.

The values for the product’s principal characteristics have been replaced by ranges that more accurately reflect local production conditions.

3.2.   Method of production:

The planting density has been amended since the distance concerned was difficult for the inspection body to check and so was therefore superfluous.

The maximum density per hectare has been increased from 1 500 plants to 2 000 and consequently the maximum yield per hectare has been increased from 2 250 to 3 000 kg.

The harvesting period and the quantity of salt used in preparation have been specified so as to make the production specification more exact and inspection more effective.

3.3.   National requirements:

The provisions that conferred upon the Sicilian regional authorities tasks that more properly fall within the remit of the approved inspection body have been deleted.

The arrangements for the checks carried out by the competent inspection body have been brought into line with Articles 10 and 11 of Regulation (EC) No 510/2006.

SINGLE DOCUMENT

COUNCIL REGULATION (EC) No 510/2006

‘CAPPERO DI PANTELLERIA’

EC No: IT-PGI-0317-0307-29.05.2007

PGI ( X ) PDO ( )

1.   Name:

‘Cappero di Pantelleria’

2.   Member State or Third Country:

Italy

3.   Description of the agricultural product or foodstuff:

3.1.   Type of product (Annex III):

| Class 1.6. | Fruit, vegetables and cereals, fresh or processed |
| --- | --- |

Class 1.6.

Fruit, vegetables and cereals, fresh or processed

3.2.   Description of the product to which the name in (1) applies:

On release for consumption, ‘Cappero di Pantelleria’ is spherical or almost spherical, rarely oblong or conical, and green to mustard-coloured. It has a strong, aromatic smell, with no trace of mould or extraneous odours. It has the aromatic, salty flavour characteristic of Pantelleria capers with sea salt. Capers used in the production of ‘Cappero di Pantelleria’ must be from plants of the botanical species ‘Capperis spinosa’, variety ‘inermis’, cultivar ‘nocellara’. Other characteristics are:

| — | moisture content: from 50 % to 70 %, |
| --- | --- |

—

moisture content: from 50 % to 70 %,

| — | size: from 4 mm to 15 mm, |
| --- | --- |

—

size: from 4 mm to 15 mm,

| — | sea salt in the pack: no more than 25 % of the weight of the capers. |
| --- | --- |

—

sea salt in the pack: no more than 25 % of the weight of the capers.

3.3.   Raw materials (for processed products only):

—

3.4.   Feed (for products of animal origin only):

—

3.5.   Specific steps in production that must take place in the identified geographical area:

All stages in the growing and preparation of ‘Cappero di Pantelleria’, from sowing to harvesting and subsequent salting, must take place exclusively on the Island of Pantelleria using local production methods. Harvesting must be by hand and must be staggered, leaving buds that are not sufficiently ripe on the plant. The capers must be dry salted using exclusively sea salt.

3.6.   Specific rules concerning slicing, grating, packaging, etc.:

—

3.7.   Specific rules concerning labelling:

In the designation and presentation of the Protected Geographical Indication ‘Cappero di Pantelleria’, the words ‘Cappero di Pantelleria’ and ‘Indicazione geografica protetta’ (Protected Geographical Indication) must be printed in characters of the same size and colour.

The label must also bear the name, company name and address of the packer, the address of the undertaking preparing the product on Pantelleria, the production batch and the net weight as sold. Additional information may be given in another field of vision, provided this is not of a laudatory nature and does not mislead the consumer as to the nature and characteristics of the product.

4.   Concise definition of the geographical area:

The production area of ‘Cappero di Pantelleria’ is the entire Island of Pantelleria in the Province of Trapani.

5.   Link with the geographical area:

5.1.   Specificity of the geographical area:

The Island of Pantelleria is of volcanic origin and is extremely arid, due to very little rainfall, and therefore is an ideal environment for growing capers.

5.2.   Specificity of the product:

Over the centuries, this product has become widely known for its aroma and taste. Thus the need to protect this product from other similar products grown in the Mediterranean basin but lacking its particular qualities.

The extent of the area involved, the special care taken in cultivation and the creation of efficient processing and marketing structures have made the caper plant a special crop on the island, constituting an important source of income.

5.3.   Causal link between the geographical area and the quality or characteristics of the product (for PDO) or a specific quality, the reputation or other characteristic of the product (for PGI):

The first specific, historically verified evidence for Pantelleria capers comes from the essay by Professor P. Calcara, ‘Breve cenno sulla geognosia ed agricultura dell'isola di Pantelleria’ (‘A Short Account of the Geognosy and Agriculture of the Island of Pantelleria’), published in Palermo in 1855 in the ‘Giornale della Commissione d'Agricoltura e Pastorizia in Sicilia’ (Journal of the Commission on Arable and Livestock Farming in Sicily).

This essay points out the economic-commercial value of the caper for the society of Pantelleria at that time: ‘The caper grows spontaneously along the southern coast and on the arid cliffs of the island, and the poor gather the buds in the months of July and August, before they flower, and sell them to a class of people who, after separating them according to size, press them in brine or vinegar and then put them on the market’.

The economic value of the caper for Pantelleria is also confirmed by other reliable historical sources such as the 1894 edition of the German Brockhaus encyclopaedia, under the entry ‘Pantelleria’, and Dr Pietro Brignone Boccanera in his ‘Cenni Storici su Pantelleria’ (‘A Historical Account of Pantelleria’), published in Partanna in 1908, which states that, beginning in the second half of the 19th century, ‘... the caper was cultivated and the island achieved production of 60 000 kg of capers’.

This is sufficient to show the increasing importance of the caper in the island's economy, even if secondary to the growing of grapes, and especially ‘zibibbo’ grapes. More recently, from the beginning of the 1960s, caper growing surpassed grape growing in importance and both the area under capers and caper production itself have continued to increase, the latter reaching around 1 200 tonnes in 1983.

Reference to publication of the specification:

The Ministry launched the national objection procedure with the publication of the amendment proposal for the Protected Geographical Indication ‘Cappero di Pantelleria’ in the Gazzetta Ufficiale della Repubblica Italiana.

The full text of the product specification is available at the following site:

http://www.politicheagricole.it/DocumentiPubblicazioni/Search_Documenti_Elenco.htm?txtTipoDocumento=Disciplinare%20in%20esame%20UE&txtDocArgomento=Prodotti%20di%20Qualit%E0>Prodotti%20Dop,%20Igp%20e%20Stg

or

by going directly to the home page of the Ministry (http://www.politicheagricole.it) and clicking on ‘Prodotti di Qualità’ (on the left of the screen) and finally on ‘Disciplinari di Produzione all’esame dell’UE [regolamento (CE) n. 510/2006]’.

---

| 29.1.2010 | EN | Official Journal of the European Union | C 22/52 |
| --- | --- | --- | --- |

29.1.2010

EN

Official Journal of the European Union

C 22/52

---

Publication of an application pursuant to Article 6(2) of Council Regulation (EC) No 510/2006 on the protection of geographical indications and designations of origin for agricultural products and foodstuffs

2010/C 22/12

This publication confers the right to object to the application pursuant to Article 7 of Regulation (EC) No 510/2006. Statements of objection must reach the Commission within six months of the date of this publication.

SUMMARY

COUNCIL REGULATION (EC) No 510/2006

‘ASPARAGO DI BADOERE’

EC No: IT-PGI-0005-0495-21.09.2005

PDO ( ) PGI ( X )

This summary sets out the main elements of the product specification for information purposes.

1.   Responsible department in the Member State:

Name: Ministero delle Politiche Agricole e Forestali

Address:

| Via XX Settembre 20 |
| --- |
| 00187 Roma RM |
| ITALIA |

Via XX Settembre 20

00187 Roma RM

ITALIA

Tel. +39 0646655202

Fax +39 0646655306

E-mail: saco7@politicheagricole.it

2.   Group:

Name: Consorzio dell’Asparago di Badoere

Address:

| c/o Municipio di Morgano |
| --- |
| Piazza Indipendenza 2 |
| 31050 Badoere di Morgano TV |
| ITALIA |

c/o Municipio di Morgano

Piazza Indipendenza 2

31050 Badoere di Morgano TV

ITALIA

Tel. +39 0499350001

Fax +39 0499350001

E-mail: —

Composition: Producers/processors ( X ) other ( )

3.   Type of product:

| Class 1.6. | Fresh or processed fruit, vegetables and cereals |
| --- | --- |

Class 1.6.

Fresh or processed fruit, vegetables and cereals

4.   Specification:

(summary of requirements under Article 4(2) of Regulation (EC) No 510/2006)

4.1.   Name:

‘Asparago di Badoere’

4.2.   Description:

‘Asparago di Badoere’ must consist of shoots grown from plants of the Liliacee family (genus Asparagus — species Officinalis — from the ‘Dariana’, ‘Thielim’, ‘Zeno’, ‘Avalim’ and ‘Grolim’ varieties for white asparagus and ‘Eros’, ‘Thielim’, ‘Grolim’, ‘Dariana’ and ‘Avalim’ for green).

When released for consumption, both types of ‘Asparago di Badoere’ PGI must be: intact, sound, free from damage caused by unsuitable washing, clean, fresh in appearance and colour, free from pests or damage caused by pests, unbruised, free of abnormal external moisture or any foreign smell and/or taste, crunchy, not hollow and not peeled. The cut at the base must be clean and perpendicular to the stem. In particular, white Extra Class ‘Asparago di Badoere’ PGI has a straight shoot with a very compact tip; it is white, but may develop a faint pink tint after packaging; it has a sweet taste, is neither acidic nor salty, is tender and not at all fibrous, has a slight scent of fresh vegetables and ripe corn, and barely perceptible bitter marbling; it has a diameter of between 12 and 20 mm, with a maximum variation of 6 mm between the thickest and the thinnest shoot in the same bundle or package, and a length of between 14 and 22 cm, with a maximum variation of 1 cm between the shortest and the longest shoot in the same bundle or package. White Class I ‘Asparago di Badoere’ PGI has the same characteristics as the Extra Class product as regards conformation, colour, taste and length, but is between 10 and 22 mm in diameter, with a maximum variation of 8 mm between the thickest and the thinnest shoot in the same bundle or package. Green Extra Class ‘Asparago di Badoere’ PGI has a straight shoot, possibly slightly curved at the top, and a very compact tip; the tip is a dark, glossy green and may have a violet tint, while the base (no more than 5 % of the shoot) is green with violet to white shading; it has a distinctive sweet taste, is neither acidic nor salty nor bitter, is tender and not at all fibrous, and has a lingering fruity, herbaceous scent; it has a diameter of between 12 and 20 mm, with a maximum variation of 6 mm between the thickest and the thinnest shoot in the same bundle, and a length of between 18 and 27 cm, with a maximum variation of 1 cm between the shortest and the longest shoot in the same bundle. Green Class I ‘Asparago di Badoere’ PGI has the same characteristics as the Extra Class product as regards conformation, colour and taste, but is between 10 and 22 mm in diameter, with a maximum variation of 8 mm between the thickest and the thinnest shoot in the same bundle, between 16 and 27 cm in length, with a maximum variation of 1 cm between the shortest and the longest shoot in the same bundle.

For all classes and types, a maximum tolerance of 3 % is allowed.

4.3.   Geographical area:

The production area of ‘Asparago di Badoere’ PGI consists of the municipalities of Piombino Dese and Trebaseleghe in the Province of Padua, Casale sul Sile, Casier, Istrana, Mogliano Veneto, Morgano, Paese, Preganziol, Quinto di Treviso, Resana, Treviso, Vedelago and Zero Branco in the Province of Treviso and Scorzè in the Province of Venice. ‘Asparago di Badoere’ PGI may be produced only on land within this geographical area that satisfies the conditions set out under point 4.6 below.

4.4.   Proof of origin:

Each stage in the production process is monitored, with all inputs and outputs recorded. This — along with the compilation of specific registers managed by the inspection body listing producers, packagers and the land registry parcels in which production takes place, and notification to the inspection body of the quantities produced — ensures product traceability throughout the production chain. All legal and natural persons recorded in the registers are subject to checks by the inspection body in line with the production specifications and the relevant monitoring plan.

4.5.   Method of production:

‘Asparago di Badoere’ (both types) may be grown in glasshouses or outdoors. The ‘crowns’ must be planted between 1 February and 30 June, with a maximum planting density of 22 000 plants/hectare. In any case, the crop cannot be grown again or following other types of Liliacea for at least 36 months. In addition, land may not be used for growing the asparagus for at least twelve months following crops of potatoes, carrots, beet or legumes.

Organic or chemical fertilisers may be used once a year, provided this involves at least one treatment with organic fertilisers. Chemical fertilisation may not, however, exceed the following unit values:

| — | nitrogen (N) — 150 kg/ha, |
| --- | --- |

—

nitrogen (N) — 150 kg/ha,

| — | phosphorous (P2O5) — 100 kg/ha, |
| --- | --- |

—

phosphorous (P2O5) — 100 kg/ha,

| — | potassium (K2O) — 200 kg/ha. |
| --- | --- |

—

potassium (K2O) — 200 kg/ha.

The crop must be maintained in optimum condition by carrying out regular mechanical or chemical pest and weed control.

In order to ensure healthy growth, no shoots may be harvested for at least 18 months from the date of planting, i.e. in the main growth period.

White asparagus plants must be mulched and covered with a black plastic sheet at least 0,10 mm thick, or another suitable material, in order to slow normal photosynthesis.

Harvesting must take place between 1 February and 31 May each year, i.e. after the main growth period.

The maximum yield after cleaning may not exceed 7 000 kg/hectare.

In order to ensure traceability and control and maintain consistent product quality, ‘Asparago di Badoere’ must be grown and packaged within the area defined in point 4.3.

4.6.   Link:

Both types of ‘Asparago di Badoere’ are characterised by rapid growth, ensuring that shoots have the physical properties of low fibre content and particularly bright colouring, and the distinctive organoleptic properties described in point 4.2.

Together, the soil and climate conditions in the production area (see below) are essential to ensuring the quality and originality of ‘Asparago di Badoere’ as they are responsible for its characteristic physical and organoleptic properties.

Temperatures in the production area average around 15 °C, with possible highs of 30 °C in the course of the year. The average annual rainfall of around 900 mm is normally concentrated in the spring and autumn. The conditions mean that there is no need for irrigation during the harvesting period, so the plants are not subject to any form of water stress and thus deliver top quality Badoere asparagus. In addition, the land is fertile and productive thanks to the slow-running karst rivers (the Sile, Zero and Dese and their tributaries) flowing through the production area. This makes the plants extremely robust, removing the need for any fertilisation beyond that outlined in point 4.5. In addition, low nitrogen levels allow the shoots to grow intact without visible splits or cracks. The earth in the production area is loose. ‘Asparago di Badoere’ can be grown only in deep soil with a fairly coarse to medium texture, low calcium content at the surface, subalkaline to neutral pH and good to medium drainage, with possible calcium carbonate (‘caranto’) deposits deeper down.

There is a long tradition of asparagus growing in the Veneto Region, which appears to originate from the time the Romans conquered land there.

There are countless documentary sources mentioning ‘Asparago di Badoere’, both white and green, as one of the most sought-after local products of the Veneto. In addition, it is worth remembering that the importance of Badoere in producing asparagus in the province led the municipal administration of Morgano to organise the first provincial Asparagus Fair in 1968, a tradition which still continues today. Asparagus growing is deeply ingrained in the local culture of the production area, where growing techniques are handed down from one generation to the next. The particular blend of production factors, such as the manual nature and small scale of the activity, combines with the local soil and climate conditions to make this type of activity clearly distinct from the rest of the sector. The widespread distribution and reputation of ‘Asparago di Badoere’, achieved thanks to a series of promotional campaigns, testify to the high esteem in which it is held.

4.7.   Inspection body:

The inspection body complies with standard EN 45011.

Name: CSQA Certificazioni srl

Address:

| Via S. Gaetano 74 |
| --- |
| 36016 Thiene VI |
| ITALIA |

Via S. Gaetano 74

36016 Thiene VI

ITALIA

Tel. +39 0445366094

Fax +39 0445382672

E-mail: —

4.8.   Labelling:

Asparagus labelled ‘Asparago di Badoere’ PGI must be packaged in bundles tightly tied with raffia or in suitable food packaging. The content of each package must be uniform and comprise only asparagus of the same type, quality class and thickness.

Bundles and packaging must bear a label featuring in lettering of the same size the wording ‘Asparago di Badoere PGI’, with specific reference to the type (green or white), the name or company name and the address of the producer and packager, plus the marketing class (Extra or I), the thickness and any further details required by the rules in force.

The seal of guarantee must also be affixed to each bundle or package in such a way that the seal (containing the ‘Asparago di Badoere’ PGI logo and any other indication required by the rules in force) is broken when the bundle or package is opened.

The ‘Asparago di Badoere’ PGI logo comprises a square with rounded edges, at the centre of which is a graphical image divided into two levels. In the foreground is a stylised representation of five asparagus shoots in a bundle. The background shows an architectural detail of a barchessa (open barn) in the town square, with a curved, outlined edging dividing the two levels. On the lower right-hand section is the wording ‘Asparago di Badoere’ on two lines.

---